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Dynamic treatment regimes: technical challenges and applications
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Abstract
Dynamic treatment regimes are of growing interest across the clinical sciences as these regimes provide
one way to operationalize and thus inform sequential personalized clinical decision making. A dynamic
treatment regime is a sequence of decision rules, with a decision rule per stage of clinical intervention;
each decision rule maps up-to-date patient information to a recommended treatment. We briefly review
a variety of approaches for using data to construct the decision rules. We then review an interesting
challenge, that of nonregularity that often arises in this area. By nonregularity, we mean the parameters
indexing the optimal dynamic treatment regime are nonsmooth functionals of the underlying generative
distribution. A consequence is that no regular or asymptotically unbiased estimator of these parame-
ters exists. Nonregularity arises in inference for parameters in the optimal dynamic treatment regime;
we illustrate the effect of nonregularity on asymptotic bias and via sensitivity of asymptotic, limiting,
distributions to local perturbations. We propose and evaluate a locally consistent Adaptive Confidence
Interval (ACI) for the parameters of the optimal dynamic treatment regime. We use data from the Adap-
tive Interventions for Children with ADHD study as an illustrative example. We conclude by highlighting
and discussing emerging theoretical problems in this area.
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1 Introduction
Dynamic treatment regimes, also called treatment policies, adaptive interventions or adaptive treatment
strategies, were created to inform the development of health-related interventions composed of sequences of
individualized treatment decisions. These regimes formalize sequential individualized treatment decisions via
a sequence of decision rules that map dynamically evolving patient information to a recommended treatment.
An optimal dynamic treatment regime (DTR) optimizes the expectation of a desired cumulative outcome
over a population of interest.
The estimation of optimal DTRs presents a number of interesting technical challenges and exciting open
problems, one of which is inference for nonregular parameters. In particular, if an estimated optimal DTR is
to inform clinical decisions or guide future research, it is essential to have reliable measures of uncertainty for
the estimated regime. However, many of the most commonly used approaches to estimating an optimal DTR
involve estimation and inference for parameters that are nonsmooth functionals of the underlying generative
distribution. Consequently, estimators of these quantities are necessarily nonregular and asymptotically
biased [Van der Vaart, 1991, Robins, 2004, Hirano and Porter, 2009]; standard asymptotic approximations
to the sampling distributions of these estimators cannot be used directly to form reliable confidence intervals
or to carry out hypothesis testing. The primary purpose of this paper is to present the bias and other
inferential problems related to this nonregularity and offer potential solutions for these problems in the
context of DTR research.
In general the data available for constructing an optimal DTR comes in the form of n independent
identically distributed trajectories, one for each subject, of the form (X1, A1, Y1, . . . , XT , AT , YT ) where:
Xt denotes interim subject information collected during the course of the tth treatment; At denotes the
treatment received at time t; and Yt denotes an outcome measured at the end of the tth treatment stage.
These trajectories may be collected in either a randomized (At are assigned with a known probability) or
observational (the distribution of At is not known) study. Traditionally most of the available data for use in
constructing DTRs has been observational and as a result, causal inference issues dominate the discussion of
statistical methods, Robins [1986], Herna´n et al. [2000], Murphy [2003], Robins [2004], Herna´n et al. [2006],
Moodie et al. [2007], Robins et al. [2008], Orellana et al. [2010], Schulte et al. [2013]. However a growing
number of experimental studies, called Sequential, Multiple, Assignment Randomized Trials (SMART) are
being conducted [Lavori and Dawson, 2000, Murphy, 2005a, Nahum-Shani et al., 2012a, Lei et al., 2012].
These studies generally involve two to three treatment stages (T = 2 or 3) and At is randomized at each
stage. See PSU Methodology Center [2012] for a partial list of such studies. To maintain the focus on
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Figure 1: Schematic describing the Adaptive Pharmacological and Behavioral Treatments for Children with
ADHD SMART [W. Pelham (PI)].
the bias and other inferential problems related to the nonregularity, we consider methods for use with data
collected in a sequential multiple assignment randomized trial.
The Adaptive Pharmacological and Behavioral Treatments for Children with ADHD Trial [W. Pelham
(PI); Nahum-Shani et al., 2012b, Lei et al., 2012] exemplifies the most common SMART; we use this study
for illustration. In the first stage of treatment, children are uniformly randomly assigned to either a low
dose of methylphenidate (a psychostimulant drug) or a low intensity of behavioral modification therapy.
Beginning at 2 months and monthly thereafter (for the remainder of the 8 month study), each child is
assessed for nonresponse; nonresponse occurred if two different teacher ratings concerning the child’s school
behavior fell below a prespecified criterion. If nonresponse occurs the child is re-randomized uniformly
between two tactics: intensify current treatment or augment the current treatment with the other treatment
(for example, augment methylphenidate with behavioral modification therapy). As long as the child did not
meet the criterion for nonresponse the child remained on current treatment. See Figure 1 for a schematic of
this trial.
In Section 2 we briefly review different methods for constructing optimal DTRs and provide greater detail
for one such method, Q-learning. In Section 3 we discuss the problem of asymptotic bias and show, using
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local alternatives, that bias-correcting shrinkage methods may perform infinitely worse than uncorrected
methods. In Section 4 we discuss interval estimation and propose a locally consistent confidence interval for
parameters indexing the optimal DTR. In Section 5 we examine the finite sample performance of the proposed
confidence interval using simulated data. In section 6 we perform an analysis of data from a clinical trial
involving school-aged children with ADHD. We use this trial to illustrate open problems in model selection
and high-dimensional modeling for DTRs that arise even in relatively simple settings. Section 7 provides a
general discussion of some open problems relating to estimation and inference of DTRs.
2 Review of Methods for Constructing Dynamic Treatment Regimes
Throughout we consider the setting in which there are two stages of binary treatment; this simple setting
is sufficient for us to illustrate the salient theoretical challenges. Furthermore many SMARTs including
the ADHD study described above involve two stages of binary treatment. Recall that on each subject
we observe a time-ordered trajectory (X1, A1, X2, A2, X3). The treatment A1 is randomly assigned with
probability possibly depending on X1 and A2 is randomly assigned with probability possibly depending
on (X1, A1, X2). In the ADHD study both A1 and A2 are randomized with probability 1/2 between the
binary alternatives. X1 denotes baseline (pre-randomization) subject information; A1 denotes in the initial
treatment, coded to take values in {0, 1}; X2 denotes subject information collected during the course of the
first treatment but prior to the second treatment;A2 denotes the second treatment, coded to take values in
{0, 1}; X3 denotes subject information collected during the course of the second treatment. The outcomes,
Y1 and Y2 are summaries; Y1 = y1(X1, A1, X2) and Y2 = y2(X1, A1, X2, A1, X3) where y1 and y2 are known
functions. Here we assume that both Y1 and Y2 are continuous variables that are coded so that higher values
are better. Define Y , Y1 + Y2 to be the total cumulative outcome.
In the ADHD study X1 contains more than 25 variables, some discrete and some continuous, and Xt,
t = 2, 3 contains more than 40 measurements collected each month; thus, over the course of the eight
month study the protocol dictated the collection of more then 360 measurements per subject. In general Xt,
t = 1, 2, 3 will contain a large number of repeated measurements. The current state-of-the-art is that these
measurements are summarized into low-dimensional summaries motivated by clinical judgment, exploratory
analyses and convenience; this is certainly the case in the ADHD example. An important open problem is the
development of formal feature extraction and construction techniques for DTRs. Here we assume that these
features are known. Let Ht, t = 1, 2 denote a real-valued feature vector summarizing information available
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to the decision maker at time t. Thus, H1 is a summary of information contained in X1 and H2 is summary
of information contained in (Xᵀ0 , A1, X
ᵀ
2 ). In the ADHD example, H1 contains baseline ADHD severity,
an indicator of oppositional defiant disorder, and an indicator of prior exposure to ADHD medication; H2
contains H1, as well as, an indicator of adherence to initial treatment, and month of non-response to initial
treatment.
In this two stage setting, a DTR is a pair of decision rules pi = (pi1, pi2), where pit : dom(Ht)→ dom(At)
so that a patient presenting at time t with Ht = ht is assigned treatment pit(ht). The value of a DTR pi,
denoted EpiY , is the expected outcome under the restriction that At = pit(Ht). The optimal DTR, say piopt,
satisfies EpioptY = suppi EpiY .
Methods for estimating optimal DTRs from data can be broadly classified as either indirect or direct
estimation methods [Barto and Dieterich, 2004]. Indirect estimation methods use approximate dynamic
programming with parametric, semiparametric or nonparametric methods to first estimate a series of outcome
models and then from these models infer the optimal DTR. Q-learning [Murphy, 2005b, Chakraborty and
Moodie, 2013, Qian et al., 2013, Chakraborty and Murphy, 2014], A-learning [Murphy, 2003, Robins, 2004],
regret-regression [Henderson et al., 2009] are popular indirect methods in the statistical literature. We
provide a detailed discussion of Q-learning below.
Direct estimation methods, also known as policy search methods, maximize an estimator of the expected
cumulative outcome over DTRs in a pre-specified class. Recent statistical work in this area includes marginal
structural mean models [Robins et al., 2008, Orellana et al., 2010], augmented value maximization [Zhang
et al., 2012, 2013], and outcome weighted learning [Zhao et al., 2012, 2013].
One potential advantage of indirect methods is that the requisite outcome models can be built using
standard statistical models (generalized regression models, time series models, etc.) which can be checked
for goodness of fit. This is particularly attractive when scientific theory, expert opinion can be used in
forming the outcome model. A potential drawback is that the optimal DTR is indirectly inferred from the
outcome models rather than being estimated directly. In contrast, most direct estimation methods do not
or minimally utilize outcome models and thereby are robust to model misspecification. However, direct
estimation methods generally produce estimators of the parameters (in an DTR) with higher variance than
indirect estimation methods. This fact has been recognized for some time in the computer science literature
with efforts there focused on using outcome models in combination with direct methods so as to reduce
variance [Sutton et al., 1999, Konda and Tsitsiklis, 2003]. Indeed there is a vast literature concerning both
indirect and direct methods for constructing optimal policies, (i.e., dynamic treatment regimes) in the field of
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reinforcement learning with many good introductory books [Sutton and Barto, 1998, Si et al., 2004, Busoniu
et al., 2010, Szepesva´ri, 2010, Wiering and van Otterlo, 2012]. However the focus of this work is on algorithms
for estimation; inference, e.g., confidence intervals or test statistics, that can be used in discussing the level
of confidence concerning the constructed DTR with clinical scientists, are, to our knowledge, absent.
To illustrate and discuss inferential challenges, we consider estimators constructed using Q-learning. Q-
Learning is attractive to statistical practitioners because Q-Learning can be viewed as a multi-stage extension
of regression [Nahum-Shani et al., 2012b], thus enabling much of the intuition developed in that area to be
(somewhat) easily translated to the area of DTRs. Q-Learning is an indirect method of constructing a DTR
from data; in the appendix A, we illustrate review a direct method, outcome-weighted learning, and illustrate
that the use of this method poses the same inferential challenges as Q-Learning. The problems we identify
with Q-Learning apply to many of the aforementioned estimators.
Define the Q-functions [Sutton and Barto, 1998, Murphy, 2005b] as
Q2(h2, a2) , E(Y |H2 = h2, A2 = a2),
Q1(h1, a1) , E
(
max
a2
Q2(H2, a2)
∣∣H1 = h1, A1 = a1) , (1)
so that Q2(h2, a2) measures the quality of assigning treatment a2 to a patient presenting with h2 at the
second stage, and Q1(h1, a1) measures the quality of assigning treatment a1 to a patient presenting with h1
at baseline assuming optimal treatment selection at the second stage. If the Q-functions are known, then
the optimal DTR is given by the dynamic programming solution, pidpt (ht) = arg maxat Qt(ht, at) [Bellman,
1957].
Note that pidpt (ht) = 1Qt(ht,1)−Qt(ht,0)≥0 (recall that at ∈ {0, 1}). Q-learning provides estimators of
the Q-contrasts, Qt(ht, 1) − Qt(ht, 0). Owing to the max-operator in (1), Q1 is a nonsmooth functional of
the underlying generative distribution, hence the estimand is also nonsmooth. We next illustrate how this
nonsmoothness impacts the sampling distributions of DTR estimators using Q-learning.
2.1 Q-Learning
Q-learning estimates the optimal DTR by postulating regression models for the Q-functions and then tak-
ing the plug-in dynamic programming solution. Consider linear models for the Q-functions of the form
Qt(ht, at;βt) = h
ᵀ
t,0βt,0 + ath
ᵀ
t,1βt,1 where ht,0 and ht,1 are known feature vectors constructed from ht and
βt = (β
ᵀ
t,0, β
ᵀ
t,1)
ᵀ; these feature vectors might contain splines or other nonlinear basis expansions. Recall
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that an open problem in DTR research is the development of a principled feature construction method. The
above linear model highlights a crucial difference between usual goal of constructing features for prediction
and constructing features for decision making. To see this note that from the linear model for the Q-function,
only the features ht,1 will be used by the decision rule pi
dp
t . Thus high quality features for decision making (as
opposed to prediction) should interact with the treatment at sufficiently strongly so that the pi
dp
t (ht) varies
by ht,1. At this time research focused on discovering features for decision making has been in the one-step
setting [see Gunter et al., 2011, Foster et al., 2011, Dusseldorp and Van Mechelen, 2013, Janes et al., 2013];
the multistage setting is essentially open.
The parameters indexing the Q-functions are estimated using least squares. Let Pn denote empirical
expectation, for example Pnf(Z) = n−1
∑n
i=1 f(Zi) where {Zi}ni=1 is a random sample. One version of the
Q-learning algorithm is as follows.
1. Stage 2 regression: β̂2 = arg minβ2 Pn (Y2 −Q2(H2, A2;β2))2.
2. Predicted second stage outcome: Y˜ = Y1 + maxa2 Q2(H2, a2; β̂2).
3. Stage 1 regression: β̂1 = arg minβ1 Pn
(
Y˜ −Q1(H1, A1;β1)
)2
.
The Q-learning estimator of the optimal DTR is thus pit(ht) = arg maxat Qt(ht, at; β̂t). The second stage
coefficients β̂2 are ordinary least squares estimators and are thus regular and asymptotically normal under
mild conditions (see Section 4). However, the first stage coefficients depend on the maximized second stage
Q-function; because the max operator is nonsmooth, the estimated coefficients β̂1 are in turn a nonsmooth
function of the data.
For notational simplicity from here until Section 6, Y1 ≡ 0 so that Y = Y2, and thus we will omit any
subscripts on Y . Define the following population analogs of the estimators used in Q-learning:
β∗2 , arg min
β2
P (Y −Q2(H2, A2;β2))2 ,
Y˜ ∗ , max
a2
Q2(H2, a2;β
∗
2) = H
ᵀ
2,0β
∗
2,0 +
[
Hᵀ2,1β
∗
2,1
]
+
,
β∗1 , arg min
β1
P
(
Y˜ ∗ −Q1(H1, A1;β1)
)2
,
where P denotes expectation with respect to the distribution of (X0, A1, X1, Y1, A2, X2, Y2) and the second
line follows from the fact that a2 ∈ {0, 1}. In addition, define Bt , (Hᵀt,0, AtHTt,1)ᵀ, Σt,∞ , PBtBᵀt for
t = 1, 2, and Σ̂t , PnBtBᵀt . We assume Σ̂t is invertible. Then β̂1 = Σ̂−11 PnB1Y˜ , β∗1 = Σ−11,∞PB1Y˜ ∗ so that
7
√
n(β̂1 − β∗1) = Σ̂−11
√
nPnB1(Y˜ −Bᵀ1β∗1). It is useful to decompose Σ̂−11
√
nPnB1(Y˜ −Bᵀ1β∗1) as
Sn + Σ̂−11 PnB1Un, (2)
where
Sn = Σˆ−11
√
nPnB1
[(
Hᵀ2,0β
∗
2,0 +
[
Hᵀ2,1β
∗
2,1
]
+
−Bᵀ1β∗1
)
+Hᵀ2,0
(
βˆ2,0 − β∗2,0
)]
,
Un =
√
n
([
Hᵀ2,1βˆ2,1
]
+
− [Hᵀ2,1β∗2,1]+) .
The term Sn is smooth and asymptotically normal but Un is nonsmooth in β̂2,1. To understand the impli-
cations of this nonsmoothness, fix H2,1 = h2,1. If h
ᵀ
2,1β
∗
2,1 6= 0, then Un
∣∣
H2,1=h2,1
is asymptotically normal
with mean zero. However, if hᵀ2,1β
∗
2,1 = 0 then Un
∣∣
H2,1=h2,1
=
[
hᵀ2,1
√
n(β̂2,1 − β∗2,1)
]
+
which converges to the
positive part of a mean zero normal random variable. Thus, the limiting distribution of
√
n(β̂1−β∗1) depends
abruptly on the value of β∗2,1 and the distribution of H2,1. This abruptness signals nonregular inference.
If H2,1 is composed only of continuous variables then some sceptism is natural because P [H
ᵀ
2,1β
∗
2,1 =
0] = 0. However in most clinical trials, the effect of treatment can be expected to be small (Hᵀ2,1β
∗
2,1 is the
effect of stage 2 treatment) relative to the noise level, thus even though Hᵀ2,1β
∗
2,1 may not be 0, it’s estimator
can be expected to be near 0 with high probability. And as we shall see that the limiting distribution of
√
n(β̂1 − β∗1) depends abruptly on the value of β∗2,1 and the distribution of H2,1 indicates that the small
sample behavior of
√
n(β̂1 − β∗1) is poorly approximated by fixed-parameter asymptotic results that assume
P [Hᵀ2,1β
∗
2,1 = 0] = 0 (see discussion of bias in Section 3 and evaluation of confidence intervals in Section 5).
Moving-parameter (e.g., local ) asymptotic results provide a better reflection of small sample behavior and
are provided in the Sections 3 and 4.
3 Asymptotic bias
In the study of nonregular estimators, much attention has been given to asymptotic bias, characterized
here as bias that is O(1/
√
n). Since asymptotic bias may be indicative of bias in small samples, incorrect
Type I error levels in hypothesis testing, and poor coverage rates of confidence intervals [e.g., Blumenthal
and Cohen, 1968, Casella and Strawderman, 1981, Bickel, 1981, Robins, 2004, Marchand and Strawderman,
2004, Chakraborty et al., 2009, Moodie et al., 2010], there is great interest in characterizing and reducing
asymptotic bias. Here we: (i) characterize the asymptotic bias of the first stage Q-learning estimator; (ii)
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show that the asymptotic bias can be reduced by using a shrinkage estimator; and (iii) argue that shrinking
too aggressively can lead to arbitrarily bad performance in finite samples.
We use E to denote expectation over P (the distribution of the observed data). Let c ∈ Rdim(β∗1 ) be
fixed. For any
√
n-consistent estimator β˜1 of β
∗
1 with
√
n(β˜1 − β∗1) converging in distribution to M, define
the c-directional asymptotic bias of β˜1 as
Bias(β˜1, c) , EcᵀM.
Define
g2(B2, Y ;β
∗
2) , B2(Y −Bᵀ2β∗2),
g1(B1, H2;β
∗
1 , β
∗
2) , B1
(
Hᵀ2,0β
∗
2,0 +
[
Hᵀ2,1β
∗
2,1
]
+
−Bᵀ1β∗1
)
.
Throughout we assume:
(A1) The histories H2, features B1, and outcomes Y , satisfy the moment inequalities
P ||H2||2 ||B1||2 <∞ and PY 2||B2||2 <∞.
(A2) The matrices Σt,∞ and Cov (g1, g2) are strictly positive definite.
Assumptions (A1)-(A2) are quite mild, requiring only full rank design matrices and some moment conditions.
Using standard methods it can be shown that Vn ,
√
n(βˆ2 − β∗2) is asymptotically normal with mean zero
and variance-covariance Ω = (PB2B
ᵀ
2 )
−1PB2B
ᵀ
2 (Y − Bᵀ2β∗2)2(PB2Bᵀ2 )−1. Let Σ21,21 denote the submatrix
of Ω corresponding the limiting asymptotic covariance of
√
n(βˆ2,1−β∗2,1) and Σˆ21,21 the corresponding plug-in
estimator. The following result is proved in Appendix B.
Theorem 3.1. Assume (A1) and (A2) and let c ∈ Rdim(β∗1 ) be fixed. Then:
Bias(β̂1, c) =
cᵀΣ−11,∞P
[
B1
√
Hᵀ2,1Σ21,21H2,11Hᵀ2,1β∗2,1=0
]
√
2pi
.
The asymptotic bias of Q-learning is nonzero when the second stage treatment effect, Hᵀ2,1β
∗
2,1, satisfies
P (Hᵀ2,1β
∗
2,1 = 0) > 0.
A common strategy for reducing asymptotic bias in Q-learning is to shrink the predicted outcome Y˜ .
Moodie et al. [2010] proposed a hard-thresholding approach; Chakraborty et al. [2009] proposed a soft-
thresholding estimator; and more recently Song et al. [2011] proposed a penalized version of Q-learning.
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We use the soft-thresholding estimator proposed by Chakraborty et al. [2009] as an illustrative example.
Chakraborty et al. [2009] illustrate, using simulation studies, that soft-thresholding reduces bias in small
samples. Define
Y˜ σ , β̂ᵀ2,0H2,0 +
[
Hᵀ2,1β̂2,1
]
+
(
1− σH
ᵀ
2,1Σ̂21,21H2,1
n(β̂ᵀ2,1H2,1)2
)
+
, (3)
where σ is nonnegative constant. For positive values of σ, the soft-thresholding estimator shrinks the
nonsmooth part of the predicted outcome towards zero. The first stage soft-thresholding estimators are
given by
β̂σ1 , arg min
β1
Pn
(
Y˜ σ −Q1(H1, A1;β1)
)2
.
The following result is proved in Appendix B.
Theorem 3.2. Assume (A1) and (A2) and let c ∈ Rp1 be fixed. Then:
1.
∣∣Bias(β̂σ1 , c)∣∣ ≤ ∣∣Bias(β̂1, c)∣∣ for any σ ≥ 0.
2. If Bias(β̂1, c) 6= 0 then for σ > 0
Bias(β̂σ1 , c)
Bias(β̂1, c)
= exp{−σ/2} − σ
∫ ∞
√
σ
1
x
exp{−x2/2}dx.
Chakraborty et al. [2009] recommend σ = 3 which corresponds to an approximate empirical Bayes estimator;
plugging σ = 3 into the above expression shows an approximate 13-fold reduction in asymptotic bias. The
soft-thresholding estimator has smaller asymptotic bias than Q-learning and the preceding result seems to
suggest that larger values of σ are preferred; indeed if σ → ∞ the asymptotic bias of the soft-thresholding
estimator converges to zero. These results are point-wise in the parameter space for (β1, β2); that is for any
fixed true parameter value of (β1, β2) the asymptotic bias converges to zero.
While it appears that these methods reduce asymptotic bias it is known that the methods cannot com-
pletely remove the asymptotic bias without driving the mean squared error to infinity [see, for example,
Doss and Sethuraman, 1989, Liu and Brown, 1993, Chen, 2004]. Furthermore, even considering just the
bias, if we evaluate the bias in a uniform (across the parameter space) manner the situation looks quite
different. In fact, from this viewpoint, we see that soft-thresholding may actually incur significantly more
bias in finite samples than Q-learning, especially for large values of σ. Intuitively reducing bias at one point
in the parameter space leads to increased bias at other points. We illustrate the bias both from a theoretical
viewpoint as well as providing a toy example that highlights the bias.
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Local or moving-parameter asymptotics play an important role in the theoretical study of nonsmooth
estimators, such as β̂1. Local asymptotics provide a way to understand and study the behavior of a nonsmooth
estimator in a more uniform manner across the parameter space, in particular by using generative models that
are arbitrarily ‘close’ to the problematic nonsmooth points in the parameter space. Consider the following
local asymptotic framework.
(A3) For any s ∈ Rdim(β∗2,1), there exists a sequence of local alternatives Pn converging to P in the sense
that: ∫ [√
n
(
dP 1/2n − dP 1/2
)
− 1
2
vsdP
1/2
]2
→ 0,
for some real-valued measurable function vs for which
– if β∗2,n , arg minβ Pn(Y −Q2(H2, A2;β)2, then β∗2,1,n , β∗2,1 + s/
√
n+ o(1/
√
n) and
– Pn||H2||2 ||B1||2, PnY 22 ||B2||2 are bounded sequences.
See the Appendix for the relationship between vs and s. Define Y˜
∗
n = H
ᵀ
2,0β
∗
2,0,n +
[
Hᵀ2,1β
∗
2,1,n
]
+
and
β∗1,n , arg minβ Pn(Y˜ ∗n −Q1(H1, A1;β))2. For any estimator β˜1 of β∗1 for which
√
n(β˜1 − β∗1,n) converges in
distribution under Pn to a random vector indexed by s, say M(s), define the c-directional asymptotic bias
under Pn as
Bias(β̂1, c, s) , EcᵀM(s).
The following result is proved in Appendix B.
Theorem 3.3. Assume (A1)-(A3) and let c ∈ Rdim(β∗1 ) be fixed. Further assume that P1Hᵀ2,1β∗2,1=0 > 0.
Then:
1. sup
s∈Rdim(β∗2,1)
∣∣Bias(β̂1, c, s)| ≤ ||cᵀΣ−11,∞||P
[
||B1||
√
Hᵀ2,1Σ21,21H2,11Hᵀ2,1β∗2,1=0
]
√
2pi
+ o(1).
2. sup
s∈Rdim(β∗2,1)
∣∣Bias(β̂σ1 , c, s)∣∣→∞ as σ →∞.
The preceding suggests that thresholding too aggressively may lead to large bias in finite samples; results of
this type are anticipated by Doss and Sethuraman [1989], Liu and Brown [1993], Hirano and Porter [2012].
Next we consider a toy example which more clearly illuminates the effect of thresholding on bias. Consider
data {(Ai, Yi)}ni=1 from a two-arm randomized study where: A ∈ {0, 1} denotes a randomly assigned binary
treatment; and Y ∈ R denotes the outcome coded so that higher values are better. Assume subjects
are randomized with equal probability so that P (A = 1) = 1/2. Define µ∗a , E(Y |A = a), and θ∗ ,
11
max(µ∗0, µ
∗
1) so that θ
∗ denotes mean outcome if all subjects are assigned treatment arg maxa µ∗a. Let
µ̂a , PnY 1A=a/Pn1A=a, then the plug-in estimator of θ∗ is
θ̂ = max(µ̂0, µ̂1) =
µ̂0 + µ̂1
2
+
|µ̂0 − µ̂1|
2
,
which is the sum of a smooth term, (µ̂0 + µ̂1)/2, and a non-smooth term |µ̂0 − µ̂1|/2. In this example,
the problematic area of the parameter space is ΘBad = {(µ1, µ2) ∈ R2 : µ1 = µ2}; under mild regularity
conditions it can be seen that if θ∗ /∈ ΘBad, then
√
n(θ̂ − θ∗) converges in distribution to mean zero normal
random variable, whereas if θ∗ ∈ ΘBad, then
√
n(θ̂−θ∗) converges in distribution to (Z0 +Z1)/2+ |Z0−Z1|/2
where Z0, Z1 are independent mean zero normal random variables. Thus, when θ
∗ ∈ ΘBad, since E|Z0−Z1| ≥
0 with equality only when both Z0 and Z1 are degenerate, θ̂ has positive asymptotic bias.
One approach to reducing the asymptotic bias of θ̂ is by thresholding the nonsmooth term in θ̂. Assume
that Var(Y |A = a) = 1 for a = 0, 1. For σ > 0, define
θ̂σ , µ̂0 + µ̂1
2
+
|µ̂0 − µ̂1|
2
(
1− 4σ
n(µ̂0 − µ̂1)2
)
+
, (4)
so that (4) is analogous to (3). In fact, (4) is a special case of (3) and is the resulting estimator of the mean
response at the first stage when there are no stage 2 covariates (except for the treatment indicator). Thus,
analogous arguments to those in the preceding section show that, for θ∗ ∈ ΘBad, θ̂σ has smaller asymptotic
bias than θ̂, and that this asymptotic bias decreases as σ increases. Similarly, a local asymptotic analysis
suggests that aggressive shrinkage may lead to large bias in finite samples.
We now illustrate the small sample behavior of θ̂σ using simulated data. We assume Y |A = a ∼
Normal(µa, 1) and that treatment assignment is perfectly balanced. We use 1000 Monte Carlo replications
to estimate bias for each parameter setting. The leftmost plot in Figure 2 shows the bias as a function
of the treatment effect µ∗1 − µ∗0 and tuning parameter σ for n = 10. Note that when n = 10 a standard
normal 90% confidence interval for µ∗1 − µ∗0 has a width of about two. Thus, the y-axis has been scaled to
roughly correspond to a 90% confidence interval centered around the problematic point 0. From the plot it
is clear that if µ∗1−µ∗0 = 0, larger values of σ correspond to lower bias; however, as anticipated from the local
asymptotic analysis, large values of σ cause the bias to increase dramatically as µ∗1−µ∗0 moves away from zero
but stays within the confidence interval. As the data do not contain sufficient information to differentiate
between different parameter values within the confidence interval, an adaptive shrinkage strategy based on
the estimated treatment difference µ̂1 − µ̂0 is not possible. The middle plot in Figure 2 shows the same bias
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plot for n = 100 displayed with the same y-axis as the n = 10 case; the very small yellow-red cross-section
above the region around σ = 0 is anticipated by the fixed asymptotic analysis which states for if µ∗1−µ∗0 6= 0
the bias decreases as the sample size increases. However, the rightmost plot in Figure 2 shows the bias for
n = 100 after rescaling the y-axis to reflect power (i.e., now the range of the y-axis corresponds to the length
of a standard normal 90% confidence interval for µ∗1−µ∗0 when n = 100); the figure is essentially identical to
the leftmost (n = 10) plot. The similarity of these plots after rescaling exemplifies the insights gained from
a local asymptotics approach which allows notions of ‘closeness’ to persist as the sample size increases.
Figure 2: Left: Bias, in units of 1/
√
n, as a function of effect size µ∗1 − µ∗0 and tuning parameter σ for
n = 10. Center: Bias, in units of 1/
√
n, as a function of effect size µ∗1 − µ∗0 and tuning parameter σ for
n = 100; Right: Same as center plot after rescaling y-axis.
4 Confidence intervals
If estimated optimal DTRs are to be used to inform clinical decision making or future research it is essential
that they be accompanied by reliable measures of uncertainty. Constructing valid confidence intervals from
nonregular estimators is difficult because it is impossible to uniformly consistently estimate the sampling
distribution of a nonregular estimator [Van der Vaart, 1991, Andrews, 2000, Leeb and Poetscher, 2003,
Hirano and Porter, 2012]. Estimators that reduce asymptotic bias, for example thresholding [Chakraborty
et al., 2009] and singular penalization [Song et al., 2011, Goldberg et al., 2012], were originally suggested
as methods for constructing high-quality confidence intervals for parameters in Q-learning. However, these
methods involve additional nonsmooth operations of the data and it can be shown that the confidence
intervals proposed with these estimators are inconsistent under local alternatives. Furthermore, asymptotic
bias only reflects the mean of the sampling distribution whereas confidence intervals require estimation of
the tails of the sampling distribution. Thus, in general reducing asymptotic bias is not sufficient for valid
inference.
On the other hand, confidence intervals that deliver the desired level of confidence can be used to conduct
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inference even in the presence of bias on the order 1/
√
n. In this section we: (i) review an adjusted projection
interval proposed by Robins [2004]; and (ii) propose a new procedure that is adaptive and locally consistent.
Additional discussion and potential extensions of the methods proposed here are provided in Section 7.
4.1 An adjusted projection interval
Recall that hᵀ2,1β
∗
2,1 is the second stage treatment effect (see Section 2.1) for feature vector h2,1; small
sample inferential problems occur when this second stage treatment effect is small with positive probability
(e.g., small sample bias, poor coverage properties of standard CIs). Robins [2004] using ideas similar to
those of Berger and Boos [1994] proposed an adjusted projected confidence interval. In the context of Q-
Learning this idea is as follows. For any β2,1 define Y˜ (β2,1) , maxa2 Q2(H2, a2; (β̂ᵀ2,0, β
ᵀ
2,1)) and Y˜
∗(β2,1) ,
maxa2 Q2(H2, a2; (β
∗ᵀ
2,0, β
ᵀ
2,1)); subsequently define β̂1(β2,1) , arg minβ1 Pn(Y˜1(β2,1) − Q1(H1, A1;β1))2 and
β∗1(β2,1) , arg minβ1 P (Y˜ ∗ − Q1(H1, A1;β1))2. Note that β∗1 = β∗1(β∗2,1). For β2,1 fixed, it follows from
standard arguments that
√
n(β̂1(β2,1) − β∗1(β2,1)) is regular, asymptotically normal with mean zero. Let
C(β2,1) denote the asymptotic variance-covariance matrix of
√
n(β̂1(β2,1)− β∗1(β2,1)) and let Ĉ(β2,1) denote
a consistent estimator of C(β2,1). A Wald-type asymptotic (1− α)× 100% confidence region for β∗1(β2,1) is
therefore
In,α(β2,1) ,
{
β1 ∈ Rdim(β∗1 ) : n
(
β̂1(β2,1)− β1
)ᵀ
Ĉ−1(β2,1)
(
β̂1(β2,1)− β1
)
≤ χ21−α,dim(β∗1 )
}
,
where χ2α,d is the (1 − α) × 100 percentile of a χ2-distribution with d degrees of freedom. In particular,
In,α(β∗2,1) is a valid asymptotic (1 − α) × 100% confidence interval for β∗1(β∗2,1) = β∗1 . Of course, β∗2,1 is
unknown, but βˆ2,1 is a regular asymptotically normal estimator of β
∗
2,1 and thus standard methods for
constructing confidence sets, e.g., the bootstrap or Taylor series arguments, can be used to construct a valid
(1− η)× 100% for β∗2,1, say ζn,η. Then, the union
⋃
β2,1∈ζn,η
In,α(β2,1), (5)
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is a valid (1− α− η)× 100% confidence region for β∗1 . To see this, note that
P
β∗1 /∈ ⋃
β2,1∈ζn,η
In,α(β2,1)
 = P
β∗1 /∈ ⋃
β2,1∈ζn,η
In,α(β2,1), β∗2,1 /∈ ζn,η

+ P
β∗1 /∈ ⋃
β2,1∈ζn,η
In,α(β2,1), β∗2,1 ∈ ζn,η
 ,
which is bounded above by P
(
β∗2,1 /∈ ζn,η
)
+ P
(
β∗1(β
∗
2,1) /∈ In,α(β∗2,1)
) ≤ η + α + oP (1). This confidence
interval is appealing for its simplicity but may be conservative especially when Hᵀ2,1β
∗
2,1 is bounded away
from zero with high probability. One approach to reduce conservatism is to first test H0 : β
∗
2,1 ≡ 0, if the
test rejects then In,α(β̂2,1) is used, if the test fails to reject then the projection interval (5) is used (Robins
2004). This pretesting approach is adaptive at the population level but may be conservative when the
distribution of Hᵀ2,1β
∗
2,1 has mass both near to and far from zero. A potentially less conservative approach
is to partition the observed sample into two groups according to the (estimated) magnitude of Hᵀ2,1β
∗
2,1 and
apply a conservative procedure only to observations for which Hᵀ2,1β
∗
2,1 is small. We now discuss such a
procedure.
4.2 Adaptive confidence intervals
In this section we construct a regular, i.e., locally consistent, confidence interval for linear combinations of
the first stage coefficients. Note that confidence intervals for the second stage coefficients can be obtained
using standard methods for least squares estimators. Let Σ̂1 , PnB1Bᵀ1 so that β̂1 = Σ̂−11 PnB1Y˜ and
β∗1 = Σ
−1
1,∞PB1Y˜
∗. Recall that it is not possible in general to construct a uniformly convergent estimator
of the limiting distribution of
√
n(β̂1 − β∗1) [Van der Vaart, 1991, Hirano and Porter, 2009]. For a given
constant c ∈ Rdim(β∗1 ), our approach is to bound cᵀ√n(β̂1 − β∗1) between two regular, uniformly convergent,
upper and lower bounds. Because these bounds are smooth, we can bootstrap them to form a confidence set
for cᵀβ∗1 . This strategy is similar to the work of Laber and Murphy [2011] on classification but differs in that
here the functional of interest is a fixed (rather than data-dependent) parameter and the functional is more
complicated. We present the two-stage binary-treatment case here; extensions to the case of an arbitrary
number of treatments and stages of treatment can be found in a technical report [Laber et al., 2010].
Recall that for any c ∈ Rdim(β∗1 ) cᵀ√n(β̂1 − β∗1) = cᵀΣ̂−11 PnB1(Y˜ − Bᵀ1β∗1) can be decomposed as
cᵀSn + cᵀΣ̂−11 PnB1Un, where the term Sn is smooth and asymptotically normal but Un is nonsmooth.
Also recall that Un =
√
n
([
Hᵀ2,1βˆ2,1
]
+
− [Hᵀ2,1β∗2,1]+). Our goal is to form smooth upper and lower bounds
15
on cᵀ
√
n(β̂1−β∗1). To limit conservatism, these bounds are based on the nonsmooth term Un and only involve
subjects with small second stage treatment effects, i.e., those subjects with histories h2,1 with h
ᵀ
2,1β
∗
2,1 ≈ 0.
We partition the observed data into two groups: (Group 1) subjects for whom hᵀ2,1β
∗
2,1 cannot be distin-
guished from zero; and (Group 2) subjects for whom hᵀ2,1β
∗
2,1 is unlikely to be near zero. This partitioning
is based on a “pretest” [see Olshen, 1973, Andrews, 2001b, Andrews and Soares, 2007, Cheng, 2008, An-
drews and Guggenberger, 2009]. The pretest is based on T̂ (h2,1) which is a test statistic that diverges
to +∞ when hᵀ2,1β∗2,1 is nonzero but is bounded in probability when hᵀ2,1β∗2,1 = 0. The pretest assigns
a subject with H2,1 = h2,1 to Group 1 if T̂ (h2,1) ≤ λn and Group 2 otherwise; λn is a tuning param-
eter. In what follows we assume T̂ (h2,1) = n(h
ᵀ
2,1β̂2,1)
2/hᵀ2,1Σ̂21,21h2,1 where Σ̂21,21 is the submatrix of
(PnB2Bᵀ2 )−1PnB2B
ᵀ
2 (Y − Bᵀ2 β̂2,1)2(PnB2Bᵀ2 )−1 corresponding to the plug-in estimator of the asymptotic
variance of Vn ,
√
n(β̂2,1 − β∗2,1).
The upper bound on cᵀ
√
n(β̂1 − β∗1) is given by
U(c) , cᵀSn + cᵀΣˆ−11 PnB1Un1Tˆ (H2,1)>λn
+ sup
γ∈Rdim(β∗2,1)
cᵀΣˆ−11 PnB1
([
Hᵀ2,1(Vn + γ)
]
+
− [Hᵀ2,1γ]+) 1Tˆ (H2,1)≤λn . (6)
A lower bound, say L(c), is obtained by replacing sup with inf in the above display. The intuition be-
hind this upper bound is as follows. Notice that the second term in (2), namely cᵀΣˆ−11 PnB1Un, is equal
to cᵀΣˆ−11 PnB1Un1Tˆ (H2,1)>λn + c
ᵀΣˆ−11 PnB1Un1Tˆ (H2,1)≤λn . Rewrite the Un in c
ᵀΣˆ−11 PnB1Un1Tˆ (H2,1)≤λn as[
Hᵀ2,1(Vn +
√
nβ∗2,1)
]
+
− [Hᵀ2,1√nβ∗2,1]+. Thus cᵀΣˆ−11 PnB1Un, is equal to
cᵀΣˆ−11 PnB1Un1Tˆ (H2,1)>λn
+ cᵀΣˆ−11 PnB1
([
Hᵀ2,1(Vn +
√
nβ∗2,1)
]
+
− [Hᵀ2,1√nβ∗2,1]+) 1Tˆ (H2,1)≤λn . (7)
The quantity,
[
Hᵀ2,1
√
nβ∗2,1
]
+
characterizes the degree of nonregularity of
√
n(βˆ1 − β∗1) (see Theorem 4.2
below). Replacing
√
nβ∗2,1 with γ and taking the supremum over all γ ∈ Rdim(β
∗
2,1) is one way of making the
second term in (7) insensitive to local perturbations of β∗2,1.
To use the bounds to construct a (1 − α) × 100% confidence interval for cᵀβ∗1 , first note that cᵀβ̂1 −
U(c)/√n ≤ cᵀβ∗1 ≤ cᵀβ̂1−L(c)/
√
n. We approximate the distribution of the bounds using the nonparametric
bootstrap. Let û denote the (1−α/2)×100 percentile of the bootstrap distribution of U(c), and let l̂ denote
the (α/2) × 100 percentile of the bootstrap distribution of L(c). Then, [cᵀβ̂1 − û
√
n, cᵀβ̂1 − l̂/
√
n] is the
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proposed confidence interval for cᵀβ∗1 . We term this confidence interval an adaptive confidence interval (ACI)
for reasons that will become clear shortly.
Remark. In the ACI λn is a potentially important tuning parameter. In Section 5 we demonstrate that
the double bootstrap is an effective strategy for constructing a data-driven choice of λn.
4.2.1 Theoretical results
In this section we describe the limiting behavior of the bounds L(c) and U(c) and relate them to the limiting
distribution of cᵀ
√
n(β̂1 − β∗1). We assume:
(A4) With probability one the sequence λn tends to infinity with n and satisfies λn/n→ 0.
Theorem 4.1 (Validity of population bounds). Assume (A1)-(A2) and (A4) and fix c ∈ Rdim(β∗1 ).
1. cᵀ
√
n(βˆ1 − β∗1) cᵀS∞ + cᵀΣ−11,∞P
(
B1H
ᵀ
2,1V∞1Hᵀ2,1β∗2,1>0
)
+ cᵀΣ−11,∞PB1
[
Hᵀ2,1V∞
]
+
1Hᵀ2,1β∗2,1=0.
2. If for each n, the underlying generative distribution is Pn, which satisfies (A3), then the limiting
distribution of cᵀ
√
n(βˆ1 − β∗1,n) is equal to
cᵀS∞ + cᵀΣ−11,∞P
(
B1H
ᵀ
2,1V∞1Hᵀ2,1β∗2,1>0
)
+ cᵀΣ−11,∞P
[
B1
([
Hᵀ2,1(V∞ + s)
]
+
− [Hᵀ2,1s]+) 1Hᵀ2,1β∗2,1=0] . (8)
3. The limiting distribution of U(c) under both P and under Pn is equal to
cᵀS∞ + cᵀΣ−11,∞P
(
B1H
ᵀ
2,1V∞1Hᵀ2,1β∗2,1>0
)
+ sup
γ∈Rdim(β∗2,1)
cᵀΣ−11,∞P
[
B1
([
Hᵀ2,1(V∞ + γ)
]
+
− [Hᵀ2,1γ]+) 1Hᵀ2,1β∗2,1=0] , (9)
where (Sᵀ∞, Vᵀ∞) is asymptotically multivariate normal with mean zero.
See the Appendix for a proof and the formula for the Cov(S∞,V∞). Notice that limiting distributions of
cᵀ
√
n(βˆ1−β∗1) and U(c) (or equivalently L(c)) are equal in the case Hᵀ2,1β∗2,1 6= 0 with probability one. That
is, when there is a large treatment effect for almost all patients then the upper (or lower) bound is tight.
However, when there is a non-null subset of patients for whom there is no treatment effect, then the limiting
distribution of the upper bound is stochastically larger than the limiting distribution of cᵀ
√
n(βˆ1 − β∗1).
Thus, the ACI adapts to the setting in which all patients experience a treatment effect.
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Because the distribution of (8) depends on the local alternative, s, βˆ1 is a nonregular estimator [Van der
Vaart and Wellner, 1996]. One might hope to construct an estimator of the distribution of (8) and use
this estimator to approximate the distribution of cᵀ
√
n(βˆ1 − β∗1). However, a consistent estimator of the
distribution of (8) does not exist because Pn is contiguous with respect to P (by assumption A3). To see
this, let Fs(u) be the distribution of (8) evaluated at a point, u. If a consistent estimator, say Fˆn(u), existed,
that is Fˆn(u) converges in probability to Fs(u) under Pn, then the contiguity implies that Fˆn(u) converges in
probability to Fs(u) under P . This is a contradiction (at best Fˆn(u) converges in probability to F0(u) under
P ). Because we cannot consistently estimate s and we do not know the value of s, the tightest estimable
upper bound on (8) is given by (9). As we shall next see, we are able to consistently estimate the distribution
of (9).
In order to form confidence sets, the bootstrap distributions of U(c) and L(c) are used. The next result
regards the consistency of these bootstrap distributions. Let Pˆ(b)n denote the bootstrap empirical measure,
that is, Pˆ(b)n , n−1
∑n
i=1Mn,iδTi for (Mn,1,Mn,2, . . . ,Mn,n) ∼ Multinomial(n, (1/n, 1/n, . . . , 1/n)). We use
the superscript (b) to denote that a functional has been replaced by its bootstrap analog, so that if ω , f(Pn)
then w(b) , f(Pˆ(b)n ). Denote the space of bounded Lipschitz-1 functions on R2 by BL1(R2). Furthermore,
let EM and PM denote the expectation and probability with respect to the bootstrap weights. The following
results are proved in the Appendix.
Theorem 4.2. Assume (A1)-(A2), (A4) and fix c ∈ Rdim(β∗1 ). Then (U(c),L(c)) and (U (b)(c),L(b)(c))
converge to the same limiting distribution in probability. That is,
sup
v∈BL1(R2)
∣∣∣∣Ev ((U(c),L(c)))− EMv ((U (b)(c),L(b)(c))) ∣∣∣∣
converges in probability to zero.
Corollary 4.3. Assume (A1)-(A2), (A4) and fix c ∈ Rdim(β∗1 ). Let uˆ denote the (1− α/2)× 100 percentile
of U (b)(c) and lˆ denote the (α/2)× 100 percentile of L(b)(c). Then
PM
(
cᵀβˆ1 − uˆ/
√
n ≤ cᵀβ∗1 ≤ cᵀβˆ1 − lˆ/
√
n
)
≥ 1− α+ oP (1).
Furthermore, if P (Hᵀ2,1β
∗
2,1 = 0) = 0, then the above inequality can be strengthened to equality.
The preceding results show that the ACI can be use to construct valid confidence intervals regardless of
the underlying parameters or generative model. Moreover, in settings where there is a treatment effect for
18
almost every patient, the ACI delivers asymptotically exact coverage. See Section 5 for discussion of the
choice of the tuning parameter λn.
5 Experiments
In this section we examine the small sample performance of the adaptive confidence interval (ACI) proposed
in the Section 4.2 where performance is measured in terms of coverage and average interval width. We
consider both fixed and data-driven choices for the tuning parameter λn. For a fixed value we choose
λn =
√
log log n; additional simulations taken over a range of λn values are provided in the Appendix.
These simulations show that the method is potentially sensitive to the choice of λn. Consequently, we
also consider a data-driven choice of λn, tuned using the double-bootstrap [Davison and Hinkley, 1997].
In particular, we consider a range of values of λn of the form λn = τ
√
log log n where τ ∈ [m,M ] where
0 < m < M <∞ are fixed constants. See the Appendix for the specifics of the double bootstrap algorithm.
Note that the theoretical properties of the ACI continue to hold with this adaptive scheme for choosing λn
since m
√
log log n ≤ τ√log log n ≤M√log log n so that λn satisfies (A4).
We compare the empirical performance of the ACI with λn fixed to equal
√
log log n (FACI) and λn
chosen using the double-bootstrap (DACI) with the following methods: the centered percentile bootstrap
(CPB); the centered percentile bootstrap of the soft-thresholding (ST) method of Chakraborty et al. [2009]
as described in Section 3; and the adaptive m-out-of-n (MOFN) bootstrap with data-driven tuning of
Chakraborty et al. [2013]. We also implemented and tested the projection interval described in Section 4.1
with η = 0.01, α = 0.04; results are not shown in the tables as they were too wide to be useful. The projection
interval always covered at least at the nominal level (and frequently much more – in 6 of 18 experiments it
covered 100% of the time) but it was between 1.46 and 2.07 times wider than the DACI, which also achieves
or exceeds nominal coverage. The hard-thresholding method of Moodie et al. [2010] and the penalized
approach of Song et al. [2011] are similar in both theory and performance to the soft-thresholding approach
and thus are omitted from our experiments.
Nine generative models are used in these evaluations; each of these generative models has two stages of
treatment and two treatments at each stage. Generically, each of the models can be described as follows:
• Xi ∈ {−1, 1}, Ai ∈ {−1, 1} for i ∈ {1, 2}
• P (A1 = 1) = P (A1 = −1) = 0.5, P (A2 = 1) = P (A2 = −1) = 0.5
• X1 ∼ Bernoulli(0.5), X2|X1, A1 ∼ Bernoulli(expit(δ1X1 + δ2A1))
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• Y = γ1 + γ2X1 + γ3A1 + γ4X1A1 + γ5A2 + γ6X2A2 + γ7A1A2 + ,  ∼ N(0, 1)
where expit(x) = ex/(1 + ex). This class is parameterized by nine values γ1, γ2, ..., γ7, δ1, δ2. The analysis
model uses feature vectors defined by:
H2,0 = (1, X1, A1, X1A1, X2)
ᵀ, H2,1 = (1, X2, A1)ᵀ,
H1,0 = (1, X1)
ᵀ, H1,1 = (1, X1)ᵀ.
Our analysis models are given by Q2(H2, A2;β2) , Hᵀ2,0β2,0 + H
ᵀ
2,1β2,1A2 and Q1(H1, A1;β1) , H
ᵀ
1,0β1,0 +
Hᵀ1,1β1,1A1. Below the analysis models are correctly specified (match the generative models). This avoids
conflating poor performance of confidence intervals due to misspecification with poor performance due to
nonregularity. We use a contrast encoding for A1 and A2 to allow for a comparison with Chakraborty et al.
(2009).
The form of this class of generative models is useful as it allows us to influence the degree of nonregularity
present in our example problems through the choice of the γi and δi, and in turn evaluate performance in these
different scenarios. Recall that in Q-learning, nonregularity occurs when more than one stage-two treatment
produces nearly the same optimal expected reward for a set of patient histories that occur with positive
probability. In the model class above, this occurs if the model generates histories for which γ5A2 +γ6X2A2 +
γ7A1A2 ≈ 0, i.e., if it generates histories for which Q2 depends weakly or not at all on A2. By manipulating
the values of γi and δi, we can control i) the probability of generating a patient history such that γ5A2 +
γ6X2A2 + γ7A1A2 = 0, and ii) a standardized effect size E[(γ5 + γ6X2 + γ7A1)/
√
Var(γ5 + γ6X2 + γ7A1)].
Each of these quantities, denoted by p and φ, respectively, can be thought of as measures of nonregularity.
Table 1 provides the parameter settings; the first six settings were considered by Chakraborty et al.
(2009), and are described by them as “nonregular”, “near-nonregular”, and “regular”. To these six, we have
added three additional examples labeled A, B, and C. Example A is an example of a strongly regular setting.
Example B is an example of a nonregular setting where the nonregularity is strongly dependent on the stage
1 treatment. In example B, for histories with A1 = 1, there is a moderate effect of A2 at the second stage.
However, for histories with A1 = −1, there is no effect of A2 at the second stage, i.e., both treatments at
the second stage are equally optimal. In example C, for histories with A1 = 1, there is a moderate effect
of A2, and for histories with A1 = −1, there is a small effect of A2. Thus example C is a ‘near-nonregular’
setting that behaves similarly to example B. In addition to these new examples, we give extensions of all
nine examples to a setting with three treatments at the second stage; details are given in Appendix C.
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Example γ δ Type Regularity Measures
1 (0, 0, 0, 0, 0, 0, 0)ᵀ (0.5, 0.5)ᵀ nonregular p = 1 φ = 0/0
2 (0, 0, 0, 0, 0.01, 0, 0)ᵀ (0.5, 0.5)ᵀ near-nonregular p = 0 φ =∞
3 (0, 0,−0.5, 0, 0.5, 0, 0.5)ᵀ (0.5, 0.5)ᵀ nonregular p = 1/2 φ = 1.0
4 (0, 0,−0.5, 0, 0.5, 0, 0.49)ᵀ (0.5, 0.5)ᵀ near-nonregular p = 0 φ = 1.02
5 (0, 0,−0.5, 0, 1.0, 0.5, 0.5)ᵀ (1.0, 0.0)ᵀ nonregular p = 1/4 φ = 1.41
6 (0, 0,−0.5, 0, 0.25, 0.5, 0.5)ᵀ (0.1, 0.1)ᵀ regular p = 0 φ = 0.35
A (0, 0,−0.25, 0, 0.75, 0.5, 0.5)ᵀ (0.1, 0.1)ᵀ regular p = 0 φ = 1.035
B (0, 0, 0, 0, 0.25, 0, 0.25)ᵀ (0, 0)ᵀ nonregular p = 1/2 φ = 1.00
C (0, 0, 0, 0, 0.25, 0, 0.24)ᵀ (0, 0)ᵀ near-nonregular p = 0 φ = 1.03
Table 1: Parameters indexing the example models.
We first provide confidence intervals for the coefficient of A1 (the treatment variable), β
∗
1,1,1 in settings in
which there are two or three treatments at stage 2. (The three-treatment version of the ACI is given by Laber
et al. [2010].) Note that given the working models and generative models defined by the parameter settings
in Table 10, we can determine the exact value of any parameter cᵀβ∗1 of interest to set the ground truth for
our experiments. Table 2 shows the estimated coverage for the coefficient of A1, β
∗
1,1,1. This simulation uses
a sample size of 150, a total of 1000 Monte Carlo replications and 1000 bootstrap samples. Target coverage
is 0.95. The CPB fares poorly in terms of coverage, falling significantly below nominal coverage on seven of
nine examples. The ST method fails to cover for examples A, B and C. Recall that the ST method has not
been developed for the setting in which there are more than two treatments at the second stage.
The coefficient of A1 is perhaps most relevant from a clinical perspective. However, from a methodological
point of view, other contrasts can be illuminating. Table 4 shows the estimated coverage for the intercept
using the same generative models. The coverage of the CPB and ST methods is quite poor; the CPB
attains nominal coverage on only two of the nine examples, and the ST never achieves nominal coverage.
Particularly disturbing is that the ST method falls more than 30% below nominal levels. In contrast, the
FACI and DACI deliver nominal coverage on all examples. Table 5 shows the average interval widths; the
DACI is the narrowest among the covering methods.
6 Analysis of the ADHD study
In this section we illustrate the use of the ACI on data from the Adaptive Pharmacological and Behavioral
Treatments for Children with ADHD Trial (Nahum-Shani et al. 2012a; Lei et al. 2012). The ADHD data
we use here consists of n = 138 trajectories which are a subset of the original N = 155 observations. This
subset was formed by removing the N − n = 17 subjects who were either never randomized to an initial
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Two txts
at stage 2
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
NR
Ex. C
NNR
CPB 0.934* 0.935* 0.930* 0.933* 0.938 0.928* 0.939 0.925* 0.928*
FACI 0.989 0.987 0.967 0.969 0.954 0.952 0.950 0.962 0.962
DACI 0.968 0.971 0.958 0.961 0.949 0.943 0.949 0.953 0.953
MOFN 0.965 0.966 0.957 0.958 0.952 0.945 0.949 0.954 0.959
ST 0.948 0.945 0.938 0.942 0.952 0.943 0.919* 0.759* 0.762*
All three of the FACI, DACI, and MOFN methods deliver nominal coverage on all of the examples. The FACI in
particular is conservative on examples one and two. The average interval diameters are shown in Table 3; this is to
be expected given that it is based on upper and lower bounds. However, we note that the DACI, whose λn is tuned
using the double bootstrap, has a much smaller width than the FACI, particularly in the three-treatment examples.
It is the narrowest among the methods that cover in all examples.
Three txts
at stage 2
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
NR
Ex. C
NNR
CPB 0.933* 0.938 0.915* 0.921* 0.931* 0.907* 0.940 0.885* 0.895*
FACI 0.999 0.999 0.967 0.968 0.963 0.969 0.958 0.969 0.969*
DACI 0.987 0.987 0.952 0.955 0.957 0.945 0.953 0.940 0.945
Table 2: Monte Carlo estimates of coverage probabilities of confidence intervals for the main effect of
treatment, β∗1,1,1 at the 95% nominal level. Estimates are constructed using 1000 datasets of size 150 drawn
from each model, and 1000 bootstraps drawn from each dataset. Estimates significantly below 0.95 at the
0.05 level are marked with ∗. There is no ST or MOFN method when there are three treatments at Stage 2.
Examples are designated NR = nonregular, NNR = near-nonregular, R = regular.
Two txts
at stage 2
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
NR
Ex. C
NNR
CPB 0.385* 0.385* 0.430* 0.430* 0.457 0.436* 0.451 0.428* 0.428*
FACI 0.490 0.490 0.481 0.481 0.483 0.471 0.474 0.484 0.484
DACI 0.442 0.441 0.470 0.470 0.482 0.469 0.474 0.473 0.473
MOFN 0.443 0.443 0.474 0.474 0.489 0.486 0.482 0.488 0.488
ST 0.339 0.339 0.426 0.427 0.469 0.436 0.480* 0.426* 0.424*
Three txts
at stage 2
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
NR
Ex. C
NNR
CPB 0.446* 0.446 0.518* 0.518* 0.567* 0.518* 0.557 0.508* 0.507*
FACI 0.700 0.700 0.652 0.652 0.637 0.632 0.617 0.661 0.662
DACI 0.564 0.564 0.590 0.590 0.617 0.591 0.604 0.596 0.597
Table 3: Monte Carlo estimates of the mean width of confidence intervals for the main effect of treatment
β∗1,1,1 at the 95% nominal level. Estimates are constructed using 1000 datasets of size 150 drawn from each
model, and 1000 bootstraps drawn from each dataset. Models have two treatments at each of two stages.
Widths with corresponding coverage significantly below nominal are marked with ∗. There is no ST or
MOFN method when there are three treatments at Stage 2. Examples are designated NR = nonregular,
NNR = near-nonregular, R = regular.
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Two txts
at stage 2
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
NR
Ex. C
NNR
CPB 0.892* 0.908* 0.924* 0.925* 0.940 0.930* 0.936 0.925* 0.931*
FACI 0.952 0.962 0.952 0.954 0.950 0.953 0.947 0.952 0.954
DACI 0.940 0.946 0.946 0.948 0.947 0.945 0.951 0.952 0.947
MOFN 0.944 0.947 0.948 0.948 0.952 0.942 0.951 0.950 0.950
ST 0.935* 0.930* 0.889* 0.878* 0.891* 0.620* 0.687* 0.686* 0.663*
Table 4: Monte Carlo estimates of coverage probabilities of confidence intervals for the coefficient of the
intercept, β∗1,0,1 at the 95% nominal level. Estimates are constructed using 1000 datasets of size 150 drawn
from each model, and 1000 bootstraps drawn from each dataset. Estimates significantly below 0.95 at the
0.05 level are marked with ∗. Examples are designated NR = nonregular, NNR = near-nonregular, R =
regular.
Two txts
at stage 2
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
NR
Ex. C
NNR
CPB 0.404* 0.404* 0.430* 0.429* 0.457 0.449* 0.450 0.428* 0.428*
FACI 0.506 0.506 0.481 0.481 0.483 0.490 0.474 0.490 0.490
DACI 0.459 0.459 0.466 0.466 0.481 0.482 0.473 0.473 0.473
MOFN 0.475 0.476 0.469 0.470 0.488 0.486 0.477 0.483 0.483
ST 0.344* 0.344* 0.427* 0.427* 0.466* 0.469* 0.474* 0.430* 0.428*
Table 5: Monte Carlo estimates of the mean width of confidence intervals for the coefficient of the intercept,
β∗1,0,1 at the 95% nominal level. Estimates are constructed using 1000 datasets of size 150 drawn from each
model, and 1000 bootstraps drawn from each dataset. Models have two treatments at each of two stages.
Widths with corresponding coverage significantly below nominal are marked with ∗. Examples are designated
NR = nonregular, NNR = near-nonregular, R = regular.
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treatment (14 subjects), or had massive item missingness (3 subjects). A description of each of the variables
is provided in Table 6. Notice that the outcomes Y1 and Y2 satisfy Y1 + Y2 ≡ Y , where Y is the teacher
X1,1 ∈ [0, 3] : Baseline symptoms. Teacher-reported mean ADHD symptom score. Measured at
the end of the school year preceding the study.
X1,2 ∈ {0, 1} : ODD diagnosis. Indicator of a diagnosis of ODD (oppositional defiant disorder)
at baseline, coded so that 0 corresponds to no such diagnosis.
X1,3 ∈ {0, 1} : Prior med. exposure. Indicator that subject received ADHD medication in the
prior year, coded so that 0 corresponds to no ADHD medication.
A1 ∈ {−1, 1} : 1st stage treatment. Coded so that −1 corresponds to medication while 1 corre-
sponds to behavioral modification therapy.
1NonRsp : Indicator of non-response, i.e. that a patient was re-randomized to a second-stage
treatment during the study. Non-response was determined on the basis of two
measures the Impairment Rating Scale (IRS) (Fabiano et al. 2006) and an indi-
vidualized list of target behaviors (ITB) (e.g., Pelham et al. 1992). The criterion
for nonresponse at each month was an average performance of less than 75 on the
ITB and a rating of impairment in at least one domain on the IRS. These were
measured beginning in week 8 of the study, and montly thereafter.
Y1 , Y · (1− 1NonRsp) : First stage outcome of responders, i.e. those who were not re-randomized (see
definition of Y and Y˜ below).
X2,1 ∈ {0, 1} : Adherence. Indicator of subject’s adherence to their initial treatment. Adherence
is coded so that a value of 0 corresponds to low adherence (taking less than 100%
of prescribed medication or attending less than 75% of therapy sessions) while a
value of 1 corresponds to high adherence.
X2,2 ∈ {2, 8} : Month of non-response. Month during school year of observed non-response and
re-randomization (not used for responders) Two subjects did not follow protocol
and were re-randomized during month 8.
A2 ∈ {−1, 1} : 2nd stage treatment. Coded so that A2 = −1 corresponds to augmenting the initial
treatment with the treatment not received initially, and A2 = 1 corresponds to
enhancing (increasing the dosage of) the initial treatment.
Y ∈ {1, 2, . . . , 5} : Teacher-reported Teacher Impairment Rating Scale (TIRS5) item score 8 months
(32 weeks) after initial randomization to treatment (Fabiano et al. 2006). The
TIRS5 is coded so that higher values correspond to better clinical outcomes.
Y2 , Y · 1NonRsp : Second stage outcome. Only used for non-responders, i.e. subjects who were re-
randomized.
Table 6: Features, treatments and the outcome for the ADHD study.
reported TIRS5 score after 32 weeks, i.e. at the end of the last month of the study (month 8).
The first step in using Q-learning is to estimate a regression model for the second stage; this anal-
ysis only uses data from subjects that were re-randomized during the 8 month study. Of the n = 138
subjects, 81 were re-randomized prior to the end of the study. The feature vectors at the second stage are
H2,0 , (1, X1,1, X1,2, X1,2, X1,3, X2,1, A1)ᵀ andH2,1 , (1, X2,1, A1)ᵀ. Thus, theQ-functionQ2(H2, A2;β2) ,
Hᵀ2,0β2,0 +H
ᵀ
2,1β2,1A2 contains an interaction term between the second stage action A2 and a subject’s initial
treatment A1, an interaction between A2 and adherence to their initial medication X2,1, a main effect for
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A2, and main effects for all the other terms. Table 7 provides the second stage least squares coefficients
along with centered percentile bootstrap interval estimates. Examination of the residuals (not shown here)
showed no obvious signs of model misspecification. In short, the linear model described above seems to fit
the data reasonably well.
Term Coeff. Estimate Lower (5%) Upper (95%)
1 Intercept β2,0,1 1.36 0.48 2.26
X1,1 Baseline symptoms β2,0,2 0.94 0.48 1.39
X1,2 ODD diagnosis β2,0,3 0.92 0.46 1.41
X1,3 Prior med. exposure β2,0,4 -0.27 -0.77 0.21
X2,1 Adherence β2,0,5 0.17 -0.28 0.66
X2,2 Month of non-response β2,0,6 0.02 -0.20 0.20
A1 1st stage txt β2,0,7 0.03 -0.18 0.23
A2 2nd stage txt β2,1,1 -0.72 -1.13 -0.35
A2 : X2,1 2nd stage txt : Adherence β2,1,2 0.97 0.48 1.52
A2 : A1 2nd stage txt : 1st stage txt β2,1,3 0.05 -0.17 0.27
Table 7: Least squares coefficients and 90% CPB interval estimates for second stage regression.
Recall that the dependent variable in the first stage regression model is the predicted future outcome Y˜1 ,
Y1 + maxa2∈{−1,1}Q2(H2, a2; βˆ2). Since the predictors used in the first stage must predate the assignment
of first treatment, the available predictors in Table 6 are baseline ADHD symptoms X1,1, diagnosis of ODD
at baseline X1,2, indicator of a subject’s prior exposure to ADHD medication X1,3, and first stage treatment
A1. The feature vectors for the second stage are H1,0 , (1, X1,1, X1,2, X1,3) and H1,1 , (1, X1,3), so that
the first stage Q-function Q1(H1, A1;β1) , Hᵀ1,0β1,0 +H
ᵀ
1,1β1,1A1 contains an interaction term between the
first stage action A1 and a subject’s prior exposure to ADHD medication X1,3, a main effect for A1, and
main effects for all other covariates. The first stage regression coefficients are estimated using least squares
βˆ1 , arg minβ1 Pn(Y˜1 −Q1(H1, A1;β1))2. Table 8 provides the least squares coefficients along with interval
estimates formed using the DACI. Plots of the residuals for this model (not shown here) show no obvious
signs of model misspecification. Again a linear model seems to provide a reasonable approximation to the
Q-function in the first stage.
To construct an estimate of the optimal DTR, recall that for any Ht = ht, t = 1, 2 the estimated optimal
DTR pˆi = (pˆi1, pˆi2) satisfies pˆit(ht) ∈ arg maxat Q(ht, at; βˆt). The coefficients in Table 7 and the form of
the second stage Q-function reveal that the second stage decision rule pˆi2 is quite simple. In particular,
pˆi2 prescribes treatment enhancement to subjects with high adherence to their initial medication and it
prescribes treatment augmentation to subjects with low adherence to their initial medication. The first
stage decision rule pˆi1 is equally simplistic. The coefficients in Table 8 show that the first stage decision rule,
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Term Coeff. Estimate Lower (5%) Upper (95%)
1 Intercept β1,0,1 2.61 2.13 3.05
X1,1 Baseline symptoms β1,0,2 0.72 0.47 1.00
X1,2 ODD diagnosis β1,0,3 0.75 0.37 1.08
X1,3 Prior med. exposure β1,0,4 -0.37 -0.80 0.01
A1 Initial txt β1,1,1 0.17 -0.02 0.36
A1 : X1,3 Initial txt : Prior med. exposure β1,1,2 -0.32 -0.59 -0.07
Table 8: Least squares coefficients and 90% DACI interval estimates for first stage regression.
pˆi1 prescribes medication to subjects who have had prior exposure to medication, and behavioral modification
to subjects who have not had any such prior exposure.
The prescriptions given by the estimated optimal DTR pˆi are excessively decisive. That is, they rec-
ommend one and only one treatment regardless of the amount of evidence in the data to support that the
recommended treatment is in fact optimal. When there is insufficient evidence to recommend a single treat-
ment as best for a given patient history, it is preferred to leave the choice of treatment to the clinician. This
allows the clinician to recommend treatment based on cost, local availability, patient individual preference,
and clinical experience. One way to assess if there is sufficient evidence to recommend a unique optimal
treatment for a patient is to construct a confidence interval for the predicted difference in mean response
across treatments. In the case of binary treatments, for a fixed patient history Ht = ht, one would construct
a confidence interval for the difference Qt(ht, 1;β
∗
t ) − Qt(h1,−1;β∗t ) = cᵀβ∗t where c = (0ᵀ, 2hᵀt,1)ᵀ. If this
confidence interval contains zero then one would conclude that there is insufficient evidence at the nominal
level for a unique best treatment.
In this example, the subject features that interact with treatment are categorical. Consequently, we
can construct confidence intervals for the predicted difference in mean response across treatments for every
possible subject history. These confidence intervals are given in table (9). The 90% confidence intervals
suggest that there is insufficient evidence at the first stage to recommend a unique best treatment for each
subject history. Rather, we would prefer not to make a strong recommendation at stage one, and leave
treatment choice solely at the discretion of the clinician. Conversely, in the second stage, the 90% confidence
intervals suggest that there is evidence to recommend a unique best treatment when a subject had low
adherence—knowledge that is important for evidence-based clinical decision making.
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Stage History Contrast
for βt,1
Lower (5%) Upper (95%) Conclusion
1 Had prior med. (2 2) -0.88 0.28 Insufficient evidence
1 No prior med. (2 0) -0.04 0.72 Insufficient evidence
2 High adherence
and BMOD
(2 2 2) -0.17 1.39 Insufficient evidence
2 Low adherence
and BMOD
(2 0 2) -2.21 -0.57 Sufficient evidence
2 High adherence
and MEDS
(2 2 -2) -0.37 1.26 Insufficient evidence
2 Low adherence
and MEDS
(2 0 -2) -2.51 -0.60 Sufficient evidence
Table 9: Confidence intervals for the predicted difference in mean response across treatments for each possible
patient history. Intervals are at the 90% leve. Confidence intervals that contain zero indicate insufficient
evidence for recommending a unique best treatment for patients with the given history.
7 Summary, open problems, and the future of DTRs
Nonregularity often arises in estimators of optimal DTRs. We discussed how nonregularity leads to asymp-
totic bias and complicates inference. Asymptotic bias can be reduced by applying shrinkage methods;
however, tuning these methods is an open problem, and over-shrinkage can be infinitely worse than no
shrinkage at all. We proposed the ACI, a locally consistent method for constructing confidence intervals
for first stage parameters in Q-learning. The ACI uses analytic bounds on cᵀ
√
n(β̂1 − β∗1). However, a
potentially less conservative strategy would be to form bounds on the (α/2) × 100 and (1 − α/2) × 100
percentiles of the sampling distribution of cᵀ
√
n(β̂1 − β∗1). For example, one could define B(c, γ) = cᵀSn +
cᵀΣˆ−11 PnB1Un1Tˆ (H2,1)>λn + c
ᵀΣˆ−11 PnB1
([
Hᵀ2,1(Vn + γ)
]
+
− [Hᵀ2,1γ]+) 1Tˆ (H2,1)≤λn . Then, for any fixed γ
and level η one could use the bootstrap to estimate the η × 100 percentile of B(c, γ), say, q̂(b)η (γ). The final
confidence interval would be
(
cᵀβ̂1 − supγ∈Rdim(β∗2,1) q̂
(b)
1−α/2(γ), c
ᵀβ̂1 − infγ∈Rdim(β∗2,1 q
(b)
α/2(γ)
)
. See [Andrews,
2001a, Cheng, 2008] and references therein for bounding probabilities rather than statistics. It would be
interesting to compare this approach with the ACI.
In our development we assumed that the features Ht were known a priori. However, in many practical
examples, including the one we considered here, Ht is a heuristic low-dimensional representation of hundreds
or even thousands of sparsely observed and irregularly spaced measurements. By design, information is
accumulating over time, if one uses linear models nested inside the sequence of treatments received, then the
model size will grow exponentially in the number of treatment stages. Principled, i.e., data-driven, methods
for feature construction and extraction are needed. On approach would be to extend dimensionality-reduction
methods from machine learning (e.g., isomap, ICA, etc.) or functional data analysis (e.g., functional principle
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components) to DTRs.
DTRs have the potential to produce better patient outcomes while simultaneously reducing cost and
patient burden. Furthermore, estimated optimal DTRs can provide important scientific insight by revealing
interactions between treatments and patient history and delayed treatment effects. However, technological
advances are continually improving the efficiency with which data can be collected, stored, and accessed.
DTR methodologies must adapt with these changes. Here we discuss two emerging areas where current DTR
methodology is insufficient. Both areas present unique estimation, inference, and computational challenges.
Infinite horizon problems. In settings where number of treatment stages is large (e.g., hundreds or
thousands) it may be appropriate to approximate the decision problems as having an infinite number of time
points. An important area where such decision problems arise is mobile-health (mHealth) where interventions
are delivered using smartphones or other mobile devices [see, for example, Kelly et al., 2012]. Mobile devices
present unprecedented opportunity for collecting patient information and delivering interventions in situ,
and thereby potentially narrowing the so-called research-practice gap [Bickman et al., 2012]. However, the
breadth of opportunities presented by mHealth are matched by their technical challenges. As the number of
decision points grows large it becomes infeasible to have separate models for the Q-function at each decision
point, in this case additional structure, for example, that the generative model can be characterized as a
stationary Markov Decision Process [MDP, Putterman, 1994], is useful. Existing methods for estimating
an optimal DTR in the MDP setup [Sutton and Barto, 1998] are highly algorithmic and their statistical
properties are largely unknown. There are tremendous opportunities for translating these algorithms into
a statistical framework and characterizing their statistical properties, e.g., convergence rates and limiting
distribution theory.
Spatial decision processes. In some applications, for example, adaptive wildlife management, separate
treatments must be administered across a series of spatial locations at each time point. The treatment
assignment at one spatial location may affect the outcomes at neighboring locations. Furthermore, the total
number of treatments than can be administered across all the spatial locations is often limited by budget or
other resource constraints. Thus, it is not feasible to estimate a separate DTR at each spatial location but
rather a single large DTR recommending treatments for all spatial locations simultaneously is needed. That
is, a DTR in this setting is a sequence of functions mapping up-to-date information at all spatial locations
to a treatment recommendation at every spatial location. Q-learning, as described, cannot be applied as the
dimension of the model grows exponentially in the number of spatial locations. Suppose, for example, that
there are S spatial locations, K treatment options available at each location, and a p-dimensional feature
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vector at each spatial location; a linear model with a main effect of feature, a main effect for treatment,
and an interaction between treatments and features would contain p×KS terms. Furthermore, even if the
Q-functions were known exactly, simply computing the argmax over all KS possibilities is computationally
intractable for moderate values of S and K.
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A Appendix: Outcome Weighted Learning
Recall that the value of a DTR pi, EpiY , is the expected outcome of Y under the restriction that At = pit(Ht).
For expositional simplicity, assume P (At = 1|Ht) = 1/2 and that Y is coded so that Y ≥ 0 in this
section. Then a change of measure implies that the value EpiY = 4P
(
Y 1A1=pi1(H1)1A2=pi2(H2)
)
; the empirical
analog is 4Pn
(
Y 1A1=pi1(H1)1A2=pi2(H2)
)
. Note the resemblance to the classification rate. As in classification,
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directly maximizing the empirical value over a class of DTRs is a discrete optimization problem and is
usually computationally burdensome. Zhao et al. [2013] solve a concave relaxation of this problem by
replacing the nonsmooth indicator functions with concave surrogates. Consider decision rules of the form
pit(ht) = 1hᵀt,1ψt,1≥0 where ht,1 is a known feature of ht. Note that 1At=pit(Ht) = 1(2At−1)Hᵀt,1ψt,1≥0. Let
φ : R→ R be a concave function that satisfies φ(z) ≤ k + 1z≥0 for all z where k is a constant. A version of
the algorithm is as follows.
1. Stage 2 optimization: ψ̂2,1 = arg maxψ2,1 PnY φ
(
(2A2 − 1)Hᵀ2,1ψ2,1
)
.
2. Stage 1 optimization: ψ̂1,1 = arg maxψ1,1 PnY 1(2A2−1)Hᵀ2,1ψ̂2,1≥0φ
(
(2A1 − 1)Hᵀ1,1ψ1,1
)
.
The estimator of the optimal DTR is thus pit(ht) = 1hᵀt,1ψ̂t,1≥0. For illustration we use φ(z) = 1− (1− z)
2.
Define the population parameters:
ψ∗2,1 , arg min
ψ2,1
P
[
Y (1− (2A2 − 1)Hᵀ2,1ψ2,1)2
]
,
ψ∗1,1 , arg min
ψ1,1
P
[
Y 1(2A2−1)Hᵀ2,1ψ∗2,1≥0(1− (2A1 − 1)H
ᵀ
1,1ψ1,1)
2
]
.
In addition, define Ψ1 , PY H1,1Hᵀ1,11(2A2−1)Hᵀ2,1ψ∗2,1≥0 and the corresponding plugin estimator Ψ̂1 ,
PnY H1,1Hᵀ1,11(2A2−1)Hᵀ2,1ψ̂2,1≥0, which we assume is invertible. Then
√
n(ψ̂1,1−ψ∗1,1) =
√
nΨ̂−11 PnY H1,1(2A1−
1)1(2A1−1)Hᵀ2,1ψ̂2,1≥0(1− (2A1 − 1)H
ᵀ
1,1ψ
∗
1,1) which can be decomposed as
Tn +
√
nΨ̂−11 PnY H1,1(2A1 − 1)(1− (2A1 − 1)Hᵀ1,1ψ∗1,1)Ln,
where
Tn = Ψ̂−11
√
n(Pn − P )
[
Y H1,1(2A1 − 1)(1− (2A1 − 1)Hᵀ1,1ψ∗1,1)1(2A2−1)Hᵀ2,1ψ∗2,1≥0
]
,
Ln = 1(2A2−1)Hᵀ2,1ψ̂2,1≥0 − 1(2A2−1)Hᵀ2,1ψ∗2,1≥0.
The term Tn is smooth and asymptotically normal under mild conditions whereas Ln is nonsmooth. If
h2,1 satisfies h
ᵀ
2,1ψ
∗
2,1 = 0 then Ln
∣∣
H2,1=h2,1
converges in distribution to a Bernoulli random variable with
probability of success equal to 1/2. On the other hand, if hᵀ2,1ψ
∗
2,1 6= 0 then Ln
∣∣
H2,1=h2,1
converges in
probability to zero. Thus, in parallel with the Q-learning case, the limiting distribution of
√
n(ψ̂1,1 − ψ∗1,1)
depends abruptly on both the value of ψ∗2,1 and the distribution of H2,1. Therefore the same theoretical
challenges as in Q-learning occur in outcome-weighted learning.
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B Appendix: Proofs
B.1 Proof of theorems in Section 3
Lemma B.1. If ω ∼ Normal(0, ν2) then E [ω]+ = ν/
√
2pi.
Proof. Let φ denote the density of a standard normal random variable. Then
E [ω]+ =
∫
R
[ω]+ φ(ω/ν)/νdω =
∫
R+
ωφ(ω/ν)/νdω = ν/
√
2pi.
Proof of Theorem 3.1. Using Theorem 4.2, part I, it follows that Bias(βˆ1, c) is equal to
E
(
cᵀΣ−11,∞PB1
[
Hᵀ2,1V∞
]
+
1Hᵀ2,1β∗2,1=0
)
.
Exchanging expectations and applying Lemma 7.1 gives the result.
Lemma B.2. If z ∼ Normal(0, 1) and σ > 0 then
E [z]+
(
1− σ/z2)
+
=
{
exp{−σ/2} − σ
∫ ∞
√
σ
exp−z2/2/zdz
}
/
√
2pi.
Proof. Let φ denote the density of a standard normal random variable, then
E [z]+
(
1− σ
z2
)
+
=
∫ ∞
√
σ
z
(
1− σ
z2
)
φ(z)dz =
{
exp{−σ/2} − σ
∫ ∞
√
σ
1
z
exp(−z2/2)dz
}
/
√
2pi.
Proof of Theorem 3.2. Notice that
√
n(βˆσ1 − β∗1) = Σ̂−11
√
nPnB1(Y˜ σ −Bᵀ1β∗1) which can be decomposed as
Σ̂−11
√
n(Pn − P )B1(Y˜ ∗ −Bᵀ1β∗1) + Σ̂−11
√
nPnB1(Y˜ σ − Y˜ ∗),
where we have used PB1(Y˜
∗ − Bᵀ1β∗1) = 0. The first term in the above display is asymptotically normal
with mean zero and thus does not contribute to the asymptotic bias. The second term in the above display
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is equal to
Σ̂−11 PnB1H
ᵀ
2,0
√
n(βˆ2,0 − β∗2,0)
+ Σ̂−11
√
nPnB1
([
Hᵀ2,1βˆ2,1
]
+
(
1− σH
ᵀ
2,1Σ̂21,21H2,1
n(βˆᵀ2,1H2,1)2
)
+
− [Hᵀ2,1β∗2,1]+
)
1Hᵀ2,1β∗2,1 6=0
+ Σ̂−11 PnB1
[
Hᵀ2,1
√
n(βˆ2,1 − β∗2,1)
]
+
(
1− σH
ᵀ
2,1Σ̂21,21H2,1
(Hᵀ2,1
√
n(βˆ2,1 − β∗2,1))2
)
+
1Hᵀ2,1β∗2,1=0.
The first two terms can be shown to have asymptotic mean zero and thus they do not contribute the
asymptotic bias. The last term converges in distribution to
Σ−11,∞P
[
B1 [Z]+
√
Hᵀ2,1Σ21,21H2,1
(
1− σ
Z2
)
+
1Hᵀ2,1β∗2,1=0
]
,
where Z is a standard normal random variable. Exchanging expectations and applying Lemma 7.2 gives the
result.
Proof of Theorem 3.3. From Theorem 4.2 part 2 it follows that Bias(βˆ1, c, s) is equal to
E
(
cᵀΣ−11,∞PB1
([
Hᵀ2,1(V∞ + s)
]
+
− [Hᵀ2,1s]+) 1Hᵀ2,1β∗2,1=0) ,
taking absolute values and applying the Cauchy-Schwarz and triangle inequalities gives the first result of the
theorem.
It can be shown that cᵀ
√
n(βˆσ1 − β∗1) converges in distribution to
cᵀΣ−11,∞PB1
([
Hᵀ2,1(V∞ + s)
]
+
(
1− σH
ᵀ
2,1Σ21,21H2,1
(Hᵀ2,1(V∞ + s))2
)
+
− [Hᵀ2,1s]+
)
1Hᵀ2,1β∗2,1=0.
Recall that H2,1 is assumed to have an intercept. Let e1 denote the first column of an dim(β
∗
2,1)× dim(β∗2,1)
identity matrix, and choose s = −V∞ + e1 log σ then as σ →∞ the above term behaves as
cᵀΣ−11,∞PB11Hᵀ2,1β∗2,1=0 log(σ),
which tends to∞ in magnitude. Thus, the supremum over s, of |Bias(βˆσ1 , c, s)| must be at least as large.
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B.2 Proof of theorems in Section 4
In the main body we assumed a single terminal reward Y , here, to cover a more general case we assume that
an intermediate reward, Y1 may be observed at the end of the first stage as well as a terminal reward Y2.
Thus, one seeks to maximize Epi(Y1 +Y2) where Epi denotes expectation with respect to the joint distribution
of the trajectory under the restriction that At = pit(Ht), t = 1, 2. Throughout this section, let K denote
a sufficiently large positive constant that may vary from line to line. Let Dp denote the space of p × p
symmetric positive definite matrices equipped with the spectral norm, and for any k ∈ (0, 1), let Dkp denote
the subset of Dp with members having eigenvalues in the range [k, 1/k]. For any class of real-valued functions
F , let ρP (f) , (P (f − Pf)2)1/2 denote the centered L2-norm on F , l∞(F) denote the space of uniformly
bounded real-valued functions on F equipped with the sup norm, and Cb(F) denote the subspace of l∞(F)
of continuous and bounded functions from F into R, respectively. Furthermore, let Gn ,
√
n(Pn − P ),
G(b)n ,
√
n(Pˆ(b)n − Pn), and PM denote probability taken with respect to the bootstrap weights defining the
bootstrap empirical measure, respectively.
B.2.1 Results for second stage parameters
In this section we will characterize the limiting distributions of the second stage parameters under fixed and
local alternatives. We will also derive the limiting distribution of the bootstrap analog of the second stage
parameters. For convenience, let pt0 , dim(β∗t,0), pt1 , dim(β∗t,1), and pt , dim(β∗t ) = pt0 + pt1 for t = 1, 2.
Theorem B.3. Assume (A1) and (A2) and fix a ∈ Rp2 , then
1. aᵀ
√
n(βˆ2 − β∗2) P aᵀZ∞,
2. aᵀ
√
n(βˆ
(b)
2 − βˆ2) PM aᵀZ∞ in P -probability; and
3. if in addition (A3) holds, aᵀ
√
n(βˆ2 − β∗2,n) Pn aᵀZ∞,
where Z∞ is a mean zero normal random vector with covariance matrix Σ−12,∞P [B2B
ᵀ
2 (Y2 −Bᵀ2β∗2)2]Σ−12,∞.
Proof. Define the class of functions F2 as
F2 , {f(b2, y2; a, β2) , aᵀb2(y2 − bᵀ2β2) : a, β2 ∈ Rp2 , ||a|| ≤ K, ||β2|| ≤ K}, (10)
and the function w2 : Dp2 × l∞(F2)× Rp2 × Rp2 → R as
w2(Σ, µ, β2, a) , µ
(
aᵀΣ−1B2(Y2 −Bᵀ2β2)
)
. (11)
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Since the estimated covariance matrices Σˆ2 = PnB2Bᵀ2 and Σˆ
(b)
2 = Pˆ
(b)
n B2B
ᵀ
2 are weakly consistent (by
Lemma B.5), we will avoid additional notation by assuming they are nonsingular for all n without loss of
generality. Thus
aᵀ
√
n(βˆ2 − β∗2) = w2(Σˆ2,Gn, β∗2 , a), aᵀ
√
n(βˆ
(b)
2 − βˆ2) = w2(Σˆ(b)2 ,G(b)n , βˆ2, a),
and aᵀ
√
n(βˆ2 − β∗2,n) = w2(Σˆ2,
√
n(Pn − Pn), β∗2,n, a).
In addition, note that aᵀZ∞ = w2(Σ2,∞,G∞, β∗2 , a) in distribution, where G∞ is a tight Gaussian process in
l∞(F2) with covariance function Cov(G∞f1,G∞f2) = P (f1 − Pf1)(f2 − Pf2). Results 1 and 3 follow from
Lemmas B.4 - B.7 and the continuous mapping theorem [Theorem 1.3.6 of Van der Vaart and Wellner 1996].
Result 2 follows from the bootstrap continuous mapping theorem [Theorem 10.8 of Kosorok 2008] together
with Lemmas B.4 - B.8.
Lemma B.4. Under (A1), the function w2 defined in (11) is continuous at points in Dp2×Cb(F)×Rp2×Rp2 .
Proof. Let  > 0 be arbitrary and let (Σ, µ, β2, a) be an element of Dp2 ×Cb(F)×Rp2 ×Rp2 . In addition, let
(Σ′, µ′, β′2, a
′) be an element of Dp2 × l∞(F)×Rp2 ×Rp2 . From the form of F and the moment assumptions
in (A1) we see that if Σ− Σ′, a− a′, and β2 − β′2 are small then so must ρP (f − f ′) be small, where
f(B2, Y2) = a
ᵀΣ−1B2(Y2 −Bᵀ2β2),
f ′(B2, Y2) = a
′ᵀΣ′−1B2(Y2 −Bᵀ2β′2).
In particular, we can choose δ > 0 sufficiently small so that ||Σ − Σ′|| + ||a − a′|| + ||β2 − β′2|| < δ implies
that ρP (f − f ′) is small enough to guarantee, by appeal to the continuity of µ, that |µ(f) − µ(f ′)| ≤ /2.
Finally, note that
∣∣w2(Σ, µ, β2, a)− w2(Σ′, µ′, β′2, a′)∣∣ ≤ |µ(f)− µ(f ′)|+ ||µ− µ′||F2 .
Let δ′ = min(δ, /2), then ||Σ−Σ′||+ ||µ− µ′||F2 + ||β2 − β′2||+ ||a− a′|| < δ′ implies that |w2(Σ, µ, β2, a)−
w2(Σ
′, µ′, β′2, a
′)| ≤ . Thus, the desired result is proved.
Having established the continuity of w2 the next step will be to characterize the limiting behavior of
β∗2,n, βˆ2, Σˆ2, Σˆ
(b)
2 , and the limiting distributions of Gn,
√
n(Pn − Pn), and
√
n(Pˆ(b)n − Pn). These limits are
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established in a series of lemmas. Once this has been accomplished we will be able to apply the continuous
mapping theorem to obtain the limiting distributions of
√
n(βˆ2 − β∗2),
√
n(βˆ − β∗2,n), and
√
n(βˆ
(b)
2 − βˆ2).
Lemma B.5. Assume (A1)-(A2), then Σˆ2 →P Σ2,∞ and Σˆ(b)2 →PM Σ2,∞ in P -probability as n → ∞.
Furthermore, if (A3) holds, then Σˆ2 →Pn Σ2,∞ as n→∞.
Proof. The first two claims follow from weak law of large numbers [Bickel and Freedman 1981, Cso¨rgo˝ and
Rosalsky 2003]. For the third claim, note that Σˆ2−Σ2,∞ = (Σˆ2−Σ2,n)+(Σ2,n−Σ2,∞) and Σˆ2−Σ2,n →Pn 0
by law of large numbers. Below we show that Σ2,n → Σ2,∞. This will complete the proof.
let c ∈ Rp2 be arbitrary and define ν , cᵀB2Bᵀ2 c. We will show that
∫
ν(dPn − dP ) = o(1). First, note
that ∫
ν(dPn − dP ) =
∫
ν(dP 1/2n + dP
1/2)(dP 1/2n − dP 1/2).
Furthermore, the absolute value of the foregoing expression is bounded above by
∫
|ν||(dP 1/2n + dP 1/2)|(dP 1/2n − dP 1/2) ≤
√∫
ν2(dP
1/2
n + dP 1/2)2
√∫
(dP
1/2
n − dP 1/2)2,
where the last inequality is simply Ho¨lder’s inequality. Next, note that owing to the inequality (
√
a+
√
b)2 ≤
2a+ 2b it follows that
∫
ν2(dP 1/2n + dP
1/2)2 ≤ 2
∫
ν2dPn + 2
∫
ν2dP = O(1),
by appeal to (A3). Now write
∫
(dP 1/2n − dP 1/2)2 = n−1
{∫ (√
n(dP 1/2n − dP 1/2)−
1
2
vdP 1/2
)2
− 1
4
∫
v2dP +
√
n
∫
vdP 1/2(dP 1/2n − dP 1/2)
}
.
The right hand side of the preceding display is equal to
O(1/n) + n−1/2
∫
vdP 1/2(dP 1/2n − dP 1/2) ≤ O(1/n) + n−1/2
√∫
v2dP
√∫
(dP
1/2
n − dP 1/2)2,
which is o(1). Thus Σ2,n → Σ2,∞.
Lemma B.6. Under (A1) and (A2), βˆ2 →P β∗2 as n→∞. If, in addition (A3) holds, then limn→∞
√
n(β∗2,n−
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β∗2) = Σ
−1
2 PvB2(Y2 −Bᵀ2β∗2).
Proof. βˆ2 →P β∗2 follows from weak law of large numbers and Slutsky’s lemma.
Recall that 0 = PnB2(Y2 −Bᵀ2β∗2,n) which we can write as
√
n(Pn − P )B2(Y2 −Bᵀ2β∗2)− Σ2,n
√
n(β∗2 − β∗2,n),
so that for sufficiently large n it follows that
√
n(β∗2,n − β∗2) = Σ−12,n
√
n(Pn − P )B2(Y2 − Bᵀ2β∗2). By appeal
to (A3) it follows that for any vector a ∈ Rp2 we have supn Pn(aᵀB2(Y2 − Bᵀ2β∗2))2 < ∞. Theorem 3.10.12
of Van der Vaart and Wellner [1996] ensures that
√
n(Pn − P )B2(Y2 −Bᵀ2β∗2)→ PvB2(Y2 −Bᵀ2β∗2)
as n→∞. This completes the proof.
Lemma B.7. Assume (A1)-(A2), then
1) Gn  P G∞ in l∞(F2), where F2 is defined in (10), and G∞ is a tight Gaussian process in l∞(F2)
with covariance function Cov(G∞f1,G∞f2) = P (f1 − Pf1)(f2 − Pf2); and
2) supω∈BL1
∣∣EMω(√n(Pˆ(b)n − Pn))− Eω(G∞)∣∣→P∗ 0 in l∞(F2).
If, in addition (A3) holds, then
3)
√
n(Pn − Pn) Pn G∞ in l∞(F2).
Proof. First note that F2 is a subset of the pairwise product of the linear classes {aᵀb2 : a ∈ Rp2} and
{y2 − bᵀ2β2 : β ∈ Rp2} each of which is VC-subgraph of index no more than p2 + 1 and P -measurable.
Under (A1), the envelope of F2, F2(B2, Y2) = K||B2||(|Y2|+K||B2||), is square integrable. This implies that
F2 is P-Donsker, and 1) follows immediately. 2) follows from Theorem 3.6.1 of van der Vaart and Wellner
(1996). For 3), note that from (A3) it follows that supf |Pnf | is a bounded sequence. The result follows
from theorem 3.10.12 of Van der Vaart and Wellner [1996].
Lemma B.8. The space Cb(F2) is a closed subset of l∞(F2) and P(G∞ ∈ Cb(F2)) = 1.
Proof. Let {µn}∞n=1 be a convergent sequence of elements in Cb(F2) and µ0 the limiting element. For the
first claim, we only need to show that ||µ0||F2 = supf∈F2 |µ0(f)| is bounded, and for any f ∈ F and  > 0,
there exists some positive δ depending on f so that |µ0(f ′) − µ0(f)| <  for all f ′ ∈ F2 and ρP (f ′, f) < δ.
The boundedness argument follows by noticing that ||µ0||F2 ≤ ||µn||F2 + ||µn−µ0||F2 for any n; in particular,
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for some fixed large enough n, ||µn||F2 is bounded by the fact µn ∈ Cb(F2), and ||µn − µ0||F2 is bounded
above by a constant due to the convergence of µn to µ0. For continuity, note that since µn converges to µ0,
we can choose n∗ so that ||µn − µ0|| < /4 for all n ≥ n∗. In addition, by the continuity of µn∗ , there exists
some δ > 0 so that |µn∗(f ′)− µn∗(f)| <  for all ρP (f ′, f) < δ. Thus
|µ0(f ′)− µ0(f)| ≤ |µ0(f)− µn∗(f)|+ |µn∗(f ′)− µ0(f ′)|+ |µn∗(f)− µn∗(f ′)|
≤ 2||µ0 − µn∗ ||F2 + |µn∗(f)− µn∗(f ′)|
≤ 3/4.
This implies that Cb(F) is closed.
Next note that G∞ is a tight Gaussian process in l∞(F2). By the argument in section 1.5 of van de
Van der Vaart and Wellner [1996], almost all sample paths f → G∞(f, ω) are uniformly ρ2-continuous, where
ρ2(f1, f2) = [P (G∞f1 −G∞f2)2]1/2 is a semimetric on F . Since ρ2(f1, f2) = [V ar(f1 − f2)]1/2 ≤ ρP (f1, f2),
the continuity of the sample paths of G∞ follows immediately.
B.2.2 A characterization of the first stage coefficients and the upper bound U(c)
In this section we present the proofs for Theorems 4.1 and 4.2. We first derive an expansion for the first stage
coefficients and two useful expansions of the upper bound U(c). The terms in the forementioned expansions
will be treated individually in subsequent sections. We will make use of the following functions.
1. w11 : Dp1 ×Dp1×p20 × l∞(F11)× l∞(F11)× Rp2 × Rp1+p2 → R is defined as
w11(Σ1,Σ12, µ, ω, ν, β) , µ
[
cᵀΣ−11 B1
(
Y1 +H
ᵀ
2,0β2,0 +
[
Hᵀ2,1β2,1
]
+
−Bᵀ1β1
)]
+cᵀΣ−11 Σ12ν0 + ω
(
cᵀΣ−11 B1H
ᵀ
2,1ν11Hᵀ2,1β∗2,1>0
)
, (12)
whereDp1×p20 is the space of p1×p20 matrices equipped with the spectral norm, and F11 =
{
f(b1, y1, h2,0, h2,1) =
aᵀ1b1
(
y1 + h
ᵀ
2,0β2,0 +
[
hᵀ2,1β2,1
]
+
− bᵀ1β1
)
+ aᵀ2b1(h
ᵀ
2,1ν1)1hᵀ2,1β∗2,1>0, : β = (β
ᵀ
1 , β
ᵀ
2,0, β
ᵀ
2,1)
ᵀ ∈ Rp1+p2 , ν =
(νᵀ0 , ν
ᵀ
1 )
ᵀ ∈ Rp2 , a1, a2 ∈ Rp1 ,max{||a1||, ||a2||, ||β||, ||ν||} ≤ K
}
.
2. w12 : Dp1 × l∞(F12)× Rp21 × Rp21 → R is defined as
w12(Σ1, µ, ν, γ) , µ
[
cᵀΣ−11 B1
([
Hᵀ2,1ν +H
ᵀ
2,1γ
]
+
− [Hᵀ2,1γ]+) 1Hᵀ2,1β∗2,1=0] , (13)
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where F12 =
{
f(b1, h2,1) = a
ᵀb1
(
[hT2,1ν + h
ᵀ
2,1γ]+ − [hᵀ2,1γ]+
)
1hᵀ2,1β∗2,1=0 : a ∈ Rp1 , γ, ν ∈ Rp21 ,max{||a||, ||ν||} ≤
K
}
.
3. ρ11 : Dp1 ×Dkp21 × l∞(F˜11)× Rp21 × Rp21 × Rp21 × R→ R, is defined as
ρ11(Σ1,Σ21,21, µ, ν, η, γ, λ) , µ
[
cᵀΣ−11 B1
([
Hᵀ2,1ν +H
ᵀ
2,1γ
]
+
− [Hᵀ2,1γ]+
)
×
1 (Hᵀ2,1ν+Hᵀ2,1η)2
H
ᵀ
2,1Σ21,21H2,1
≤λ
− 1Hᵀ2,1β∗2,1=0
], (14)
where F˜11 =
{
f(b1, h2,1) = a
ᵀb1
(
[hᵀ2,1ν − hᵀ2,1γ]+ − [hᵀ2,1γ]+
)
(1 (hᵀ2,1ν+h
ᵀ
2,1η)
2
h
ᵀ
2,1Σ21,21h2,1
≤λ
− 1hᵀ2,1β∗2,1=0), : a ∈
Rp1 , ν, η, γ ∈ Rp21 ,max{||a||, ||ν||} ≤ K,λ ∈ R,Σ21,21 ∈ Dkp21
}
.
4. ρ12 : Dp1 × l∞(F˜12)× Rp21 × Rp21 → R, defined as
ρ12(Σ1, µ, ν, η) , µ
[
cᵀΣ−11 B1
([
Hᵀ2,1ν +H
ᵀ
2,1η
]
+
− [Hᵀ2,1η]+ −Hᵀ2,1ν
)
1Hᵀ2,1β∗2,1>0
+ cᵀΣ−11 B1
([
Hᵀ2,1ν +H
ᵀ
2,1η
]
+
− [Hᵀ2,1η]+
)
1Hᵀ2,1β∗2,1<0
]
, (15)
where F˜12 =
{
aᵀb1
( [
hᵀ2,1ν + h
ᵀ
2,1η
]
+
−[hᵀ2,1η]+−hᵀ2,1ν
)
1hᵀ2,1β∗2,1>0−aᵀb1
( [
hᵀ2,1ν + h
ᵀ
2,1η
]
+
−[hᵀ2,1η]+
)
1hᵀ2,1β∗2,1<0 :
a ∈ Rp1 , ν ∈ Rp21 ,max{||a||, ||ν||} ≤ K, η ∈ Rp21
}
.
Using the foregoing functions, we have the following expressions for the first stage parameters:
cᵀ
√
n(βˆ1 − β∗1) = w11(Σˆ1, Σˆ12,Gn,Pn,
√
n(βˆ2 − β∗2), (β∗ᵀ1 , β∗ᵀ2 )ᵀ)
+ w12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1),
√
nβ∗2,1)
+ ρ12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1),
√
nβ∗2,1); (16)
√
n(βˆ1 − β∗1,n) = w11(Σˆ1, Σˆ12,
√
n(Pn − Pn),Pn,
√
n(βˆ2 − β∗2,n), (β∗ᵀ1,n, β∗ᵀ2,n)ᵀ)
+ w12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1,n),
√
nβ∗2,1,n)
+ ρ12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1,n),
√
nβ∗2,1,n), (17)
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where Σˆ12 = PnB1Hᵀ2,0. Similarly, we can express the upper bound U(c) in terms of the above functions:
U(c) = w11(Σˆ1, Σˆ12,Gn,Pn,
√
n(βˆ2 − β∗2), (β∗ᵀ1 , β∗ᵀ2 )ᵀ)
+ ρ12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1),
√
nβ∗2,1)
− ρ11(Σˆ1, Σˆ21,21,Pn,
√
n(βˆ2,1 − β∗2,1),
√
nβ∗2,1,
√
nβ∗2,1, λn)
+ sup
γ∈Rp2,1
{
w12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1), γ)
+ ρ11(Σˆ1, Σˆ21,21,Pn,
√
n(βˆ2,1 − β∗2,1),
√
nβ∗2,1, γ, λn)
}
. (18)
We will also make use of the following alternative expression for the upper bound U(c) under Pn:
U(c) = w11(Σˆ1, Σˆ12,
√
n(Pn − Pn),Pn,
√
n(βˆ2 − β∗2,n), (β∗ᵀ1,n, β∗ᵀ2,n)ᵀ)
+ ρ12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1,n),
√
nβ∗2,1,n)
− ρ11(Σˆ1, Σˆ21,21,Pn,
√
n(βˆ2,1 − β∗2,1,n),
√
nβ∗2,1,n,
√
nβ∗2,1,n, λn)
+ sup
γ∈Rp21
{
w12(Σˆ1,Pn,
√
n(βˆ2,1 − β∗2,1,n), γ)
+ ρ11(Σˆ1, Σˆ21,21,Pn,
√
n(βˆ2,1 − β∗2,1,n),
√
nβ∗2,1,n, γ, λn)
}
. (19)
Similarly, we will make use of following expression for the bootstrap analog of the upper bound:
Uˆ (b)(c) = w11(Σˆ(b)1 , Σˆ(b)12 ,
√
n(P(b)n − Pn),P(b)n ,
√
n(βˆ
(b)
2 − βˆ2), (βˆᵀ1 , βˆᵀ2 )ᵀ)
+ ρ12(Σˆ
(b)
1 , Pˆ
(b)
n ,
√
n(βˆ
(b)
2,1 − βˆ2,1),
√
nβˆ2,1)
− ρ11(Σˆ(b)1 , Σˆ(b)21,21, Pˆ(b)n ,
√
n(βˆ
(b)
2,1 − βˆ2,1),
√
nβˆ2,1,
√
nβˆ2,1, λn)
+ sup
γ∈Rp21
{
w12(Σˆ
(b)
1 , Pˆ
(b)
n ,
√
n(βˆ
(b)
2,1 − βˆ2,1), γ)
+ ρ11(Σˆ
(b)
1 , Σˆ
(b)
21,21, Pˆ
(b)
n ,
√
n(βˆ
(b)
2,1 − βˆ2,1),
√
nβˆ2,1, γ, λn)
}
. (20)
The lower bound L(c) and its bootstrap analog Lˆ(b)(c) can be expressed in a similar fashion by replacing
the sup with an inf in the expression of U(c) and Uˆ (b)(c), respectively.
By Lemmas B.9 and B.11 below, ρ11 is negligible, and w11 and w12 are continuous at desired points.
The negligibility of ρ12 can be obtained in a similar fashion. Note that the convergence of Σˆ1 and Σˆ
(b)
1 to
Σ1 and the convergence of Σˆ12 and Σˆ
(b)
12 to PB1H
ᵀ
2,0 can be obtained using similar proof techniques as in
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Lemma B.5. This together with Theorem B.3, Lemmas B.5 - B.8, and the continuous mapping theorems as
presented in the previous section, implies that the conclusions of Theorems 4.1 and 4.2 hold with
S∞ = Σ−11,∞
[
G∞
(
B1(Y1 +H
ᵀ
2,0β
∗
2,0 + [H
ᵀ
2,1β
∗
2,1]+ −Bᵀ1β∗1)
)
+ PB1H
ᵀ
2,0Z∞,0
]
and V∞ =Z∞,1,
where Zᵀ∞,0 ∈ Rp20 , Zᵀ∞,1 ∈ Rp21 , and Z∞ = (Zᵀ∞,0,Zᵀ∞,1)ᵀ = Σ−12,∞G∞[B2(Y2 −Bᵀ2β∗2)].
Lemma B.9. Assume (A1), (A2) and (A4). Then
1. supγ∈Rp21
∣∣ρ11(Σˆ1, Σˆ21,21,Pn,√n(βˆ2,1 − β∗2,1),√nβ∗2,1, γ, λn)| →P 0, and
2. supγ∈Rp21
∣∣ρ11(Σˆ(b)1 , Σˆ(b)21,21, Pˆ(b)n ,√n(βˆ(b)2,1 − βˆ2,1),√nβˆ2,1, γ, λn)∣∣→PM 0 almost surely P .
If, in addition, we assume (A3), then
3. supγ∈Rp21
∣∣ρ11(Σˆ1, Σˆ21,21,Pn,√n(βˆ2,1 − β∗2,1,n),√nβ∗2,1,n, γ, λn)∣∣→Pn 0.
Proof. First it is easy to verify that |[Hᵀ2,1ν−Hᵀ2,1γ]+− [Hᵀ2,1γ]+| ≤ |hᵀ2,1ν|. Thus for any probability measure
µ in l∞(F˜11),
|ρ11(Σ1,Σ21,21, µ, ν, η, γ, λ)| ≤ K
{
µ
(
||B1|| ||H2,1|| 1
Hᵀ2,1β
∗
2,1=0,
H
ᵀ
2,1η
||H2,1||>
√
λk−K
)
+ µ
(
||B1|| ||H2,1|| 1
Hᵀ2,1β
∗
2,1=0,
H
ᵀ
2,1η
||H2,1||<−
√
λk−K
)
+ µ
(
||B1|| ||H2,1|| 1
Hᵀ2,1β
∗
2,1 6=0,−
√
λ/k−K≤ H
ᵀ
2,1η
||H2,1||≤
√
λ/k+K
)}
for a sufficiently large constant K > 0 and a sufficiently small constant k ∈ (0, 1). Since k is held constant
there is no loss in generality taking k = 1. Define ρ′11 : l
∞(F ′11)× Rp21 × R× R→ R as
ρ′11(µ, η, δ, δ
′) = µ
(
||B1|| ||H2,1|| 1
Hᵀ2,1β
∗
2,1=0,
H
ᵀ
2,1η
||H2,1||>δ
)
+ µ
(
||B1|| ||H2,1|| 1
Hᵀ2,1β
∗
2,1=0,
H
ᵀ
2,1η
||H2,1||<δ
′
)
+ µ
(
||B1|| ||H2,1|| 1
Hᵀ2,1β
∗
2,1 6=0,δ′≤
H
ᵀ
2,1η
||H2,1||≤−δ′
)
, (21)
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where F ′11 =
{
f(b1, h2,1) = ||b1|| ||h2,1||1
hᵀ2,1β
∗
2,1=0,
h
ᵀ
2,1η
||h2,1||>δ
+||b1|| |||h2,1||1
hᵀ2,1β
∗
2,1=0,
H
ᵀ
2,1η
||h2,1||<δ
′
+||b1|| ||h2,1||1
hᵀ2,1β
∗
2,1 6=0,δ′≤
h
ᵀ
2,1η
||h2,1||≤−δ′
, η ∈
Rp21 ,max{||η||, ||δ||, ||δ′||} ≤ K
}
. Then
|ρ11(Σ1,Σ21,21, µ, ν, η, γ, λ)| ≤ Kρ′11
(
µ, η/
√
n, (
√
λ−K)/√n,−(
√
λ+K)/
√
n
)
for µ ∈ l∞(F˜11). In particular for n sufficiently large,
∣∣ρ11(Σˆ(b)1 , Σˆ(b)21,21, Pˆ(b)n ,√n(βˆ(b)2,1 − βˆ2,1),√nβˆ2,1, γ, λn)∣∣ ≤
K ρ′11
(
Pˆ(b)n , βˆ2,1, (
√
λn −K)/
√
n,−(
√
λn −K)/
√
n
)
+ ||c|| ||Σˆ(b)1 || ||
√
n(βˆ
(b)
2,1 − βˆ2,1)|| Pˆ(b)n (||B1|| ||H2,1||) 1||√n(βˆ(b)2,1−βˆ2,1)||>K ,
where we have assumed, without loss of generality, that Σˆ
(b)
21,21 is the identity matrix. By part 2 of Lemma
B.10 below, we see that the first term on the right hand side of the above display is oPM (1) almost surely P . To
deal with the second term, for any , δ > 0, let K sufficiently large so that PM
(∣∣∣∣√n(βˆ(b)2,1 − βˆ2,1)∣∣∣∣ > K) < δ
for sufficiently large n for almost all sequences P . Then
PM
(
||c|| ||Σˆ(b)1 || ||
√
n(βˆ
(b)
2,1 − βˆ2,1)||Pˆ(b)n ||B1|| ||H2,1||1|√n(βˆ(b)2,1−βˆ2,1)|>K > 
)
≤ PM
(∣∣∣∣√n(βˆ(b)2,1 − βˆ2,1)∣∣∣∣ > K) ≤ δ,
almost surely P . This completes the proof of result 2. Similar arguments can be used to prove results 1 and
3, and are omitted.
Lemma B.10. Let ρ′11 be defined in (21). Assume (A1), (A2) and (A4), then
1. ρ′11(Pn, β∗2,1, (
√
λn −K)/
√
n, (−√λn −K)/
√
n)→P 0, and
2. ρ′11(Pˆ
(b)
n , βˆ2,1, (
√
λn −K)/
√
n, (−√λn −K)/
√
n)→PM 0, P -almost surely.
If, in addition, we assume (A3), then
3. ρ′11(Pn, β
∗
2,1,n, (
√
λn −K)/
√
n, (−√λn −K)/
√
n)→Pn 0.
Proof. The class F ′11 is P -Donsker and measurable by Theorem 8.14 in Anthony and Bartlett [1999] and
Donkser preservation results (for example, see Theorem 2.10.6 in Van der Vaart and Wellner 1996). Note
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that by (A1) and (A3) supf∈F ′11 |Pf2| <∞ and supf∈F ′11 |Pnf2| is a bounded sequence. Thus, it follows that
(i) ||Pn − P || → 0 almost surely under P in l∞(F ′11), (ii) ||Pˆ(b)n − P || → 0 almost surely PM for almost all
sequences P [Lemma 3.6.16 in Van der Vaart and Wellner 1996], and (iii) ||Pn−Pn|| → 0 almost surely under
Pn in l
∞(F ′11) [Theorem 3.10.12 in Van der Vaart and Wellner 1996]. Additionally, the argument in the proof
of Lemma (B.5) shows that Σˆ1 is convergent to Σ1 under Pn, and the weak law of large numbers establishes
convergence under P . The bootstrap strong law shows that Σˆ
(b)
1 converges to Σ1 in PM probability for
almost all sequences P .
Next we show that ρ′11 is continuous at the point (P, β
∗
2,1, 0, 0). Let µn → P in l∞(F ′11), ηn → β∗2,1,
δn → 0, and δ′n → 0. We have
∣∣ρ′11(µn, ηn, δn, δ′n)− ρ′11(P, β∗2,1, 0, 0)∣∣ ≤ ∣∣ρ′11(P, ηn, δn, δ′n)− ρ′11(P, β∗2,1, 0, 0)∣∣+ ||µn − P ||,
which converges to zero by the dominated convergence theorem. The results follow from the continuous
mapping theorems and the fact that ρ′11(P, β
∗
2,1, 0, 0) = 0.
Lemma B.11. Assume (A1) and (A2). Then
1. w11 is continuous at points in (Σ1,∞,Σ12,∞, Cb(F11), P,Rp2 , (β∗ᵀ1 , β∗ᵀ2 )ᵀ);
2. w12(·, ·, ·,
√
nβ∗2,1) and w12(·, ·, ·,
√
nβ∗2,1,n) are continuous at points in (Σ1,∞, P,Rp21); and
3. w′12(Σ1, µ, ν) , supγ∈Rp21 w12(Σ1, µ, ν, γ) is continuous at points in (Σ1,∞, P,Rp21).
Proof. To prove the desired continuity of w12 and w
′
12, we will establish the stronger result that w12 is
continuous at points (Σ1,∞, P,Rp21 , γ) uniformly in γ. That is, for any Σn → Σ1,∞, probability measures
µn → P and νn → ν, we have
sup
γ
∣∣∣∣w12(Σn, µn, νn, γ)− w12(Σ1, P, ν, γ)∣∣∣∣→ 0.
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Note that
∣∣w12(Σn, µn, νn, γ)− w12(Σ1, P, ν, γ)∣∣
≤ ∣∣w12(Σn, µn, νn, γ)− w12(Σn, µn, ν, γ)∣∣+ ∣∣w12(Σn, P, ν, γ)− w12(Σ1, P, ν, γ)∣∣
+
∣∣w12(Σn, µn, ν, γ)− w12(Σn, P, ν, γ)∣∣
≤ µn
(∣∣cᵀΣ−1n B1|Hᵀ2,1(νn − ν)|∣∣)+ P (|cᵀ(Σ−1n − Σ−11,∞)B1| |Hᵀ2,1ν|)
+
∣∣∣(µn − P )(cᵀΣ−1n B1([Hᵀ2,1ν +Hᵀ2,1γ]+ − [Hᵀ2,1γ]+)1Hᵀ2,1β∗2,1=0)∣∣∣
By (A2), we have that ||Σ−1n || is bounded above for sufficiently large n, where ||·|| of a matrix denotes the spec-
tral norm of the matrix. Thus the first term in the above display is bounded by ||c|| ||Σ−1n ||µn(||B1|| ||H2,1||) ||νn−
ν|| = o(1), and the second term in the above display is bounded by ||c|| ||Σ−11 −Σ−1n ||P (||B1|| ||H2,1||)||ν|| =
o(1). For the third term, note that if ||ν|| = 0, then it is zero. Otherwise,
∣∣∣(µn − P )(cᵀΣ−1n B1([Hᵀ2,1ν +Hᵀ2,1γ]+ − [Hᵀ2,1γ]+)1Hᵀ2,1β∗2,1=0)∣∣∣
≤
∣∣∣(µn − P )(cᵀΣ−1n B1([Hᵀ2,1ν/||ν||+Hᵀ2,1γ/||ν||]+ − [Hᵀ2,1γ/||ν||]+)1Hᵀ2,1β∗2,1=0)∣∣∣ ||ν||
≤ ||µn − P ||F12 ||ν|| = o(1).
This established the continuity of w12 and hence w
′
12. The continuity of w11 can be established through
similar arguments and is therefore omitted.
C Appendix: Definitions of Three-Treatment Models
Here, we present a suite of example models similar to those of Chakraborty et al. (2009), but that have
three possible treatments at the second stage. These models are defined as follows:
• Xi ∈ {−1, 1} for i ∈ {1, 2}, A1 ∈ {−1, 1}, and A2 ∈ {(0,−0.5)ᵀ, (−1, 0.5)ᵀ, (1, 0.5)ᵀ}
• P (A1 = 1) = P (A1 = −1) = 1/2,
P (A2 = (0,−1)ᵀ) = P (A2 = (−1, 0.5)ᵀ) = P (A2 = (1, 0.5)ᵀ) = 1/3
• P (X1 = 1) = P (X1 = −1) = 1/2, P (X2 = 1|X1, A1) = expit(δ1X1 + δ2A1)
• Y1 , 0,
Y2 = ξ1 + ξ2X1 + ξ3A1 + ξ4X1A1 + (ξ5, ξ6)A2 +X2(ξ7, ξ8)A2 +A1(ξ9, ξ10)A2 + ,  ∼ N(0, 1)
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where expit(x) = ex/(1 + ex). This class is parameterized by twelve values ξ1, ξ2, ..., ξ10, δ1, δ2. The analysis
model uses histories defined by:
H2,0 = (1, X1, A1, X1A1, X2)
ᵀ (22)
H2,1 = (1, X2, A1)
ᵀ (23)
H1,0 = (1, X1)
ᵀ (24)
H1,1 = (1, X1)
ᵀ. (25)
Our working models are given byQ2(H2, A2;β2) , Hᵀ2,0β2,0+H
ᵀ
2,1β2,1,1A2,1+H
ᵀ
2,1β2,1,2A2,2 andQ1(H1, A1;β1) ,
Hᵀ1,0β1,0 +H
ᵀ
1,1β1,1A1. In Table C, for each of these models we give the probability p of generating a history
Example ξ δ Regularity
1 (0, 0, 0, 0, 0, 0, 0, 0, 0, 0)
ᵀ
(0.5, 0.5)ᵀ p = 1, φ = 0/0
2 (0, 0, 0, 0, 0.01, 0.01, 0, 0, 0, 0)
ᵀ
(0.5, 0.5)ᵀ p = 0, φ =∞
3 (0, 0,−0.5, 0, 0.5, 0.5, 0, 0, 0.5, 0.5)ᵀ (0.5, 0.5)ᵀ p = 1/2, φ = 1.0
4 (0, 0,−0.5, 0, 0.5, 0.5, 0, 0, 0.49, 0.49)ᵀ (0.5, 0.5)ᵀ p = 0, φ = 1.0204
5 (0, 0,−0.5, 0, 1.00, 1.00, 0.5, 0.5, 0.5, 0.5)ᵀ (1.0, 0.0)ᵀ p = 1/4, φ = 1.4142
6 (0, 0,−0.5, 0, 0.25, 0.25, 0.5, 0.5, 0.5, 0.5)ᵀ (0.1, 0.1)ᵀ p = 0, φ = 0.3451
A (0, 0,−0.25, 0, 0.75, 0.75, 0.5, 0.5, 0.5, 0.5)ᵀ (0.1, 0.1)ᵀ p = 0, φ = 1.035
B (0, 0, 0, 0, 0.25, 0.25, 0, 0, 0.25, 0.25)
ᵀ
(0, 0)ᵀ p = 1/2, φ = 1.00
C (0, 0, 0, 0, 0.25, 0.25, 0, 0, 0.24, 0.24)
ᵀ
(0, 0)ᵀ p = 1/2, φ = 1.00
Table 10: Parameters indexing the example models.
where each of the three possible treatments at the second stage have exactly the same effect. This is anal-
ogous to having the second stage treatment show no effect in a binary model. Furthermore, because of the
Helmert encoding we have used in our analysis models, and because of the structure of ξ, it happens that the
standardized effect size of treatment 1 versus treatment 2, treatment 1 versus treatment 3, and treatment 2
versus treatment 3 are all exactly equal in our examples. We report this as φ in Table C.
D Appendix: Additional Empirical Results
Here we present additional empirical results. Tables (11) and (12) show the estimated coverage and interval
diameter of the ACI across the nine generative models with two stages and two treatments per stage. The
results appear stable across choices of λn for which the ACI is consistent. However, the ACI becomes quite
conservative when λn is allowed to grow faster than
√
log log n.
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β1,1,1
λn =
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
R
Ex. C
R√
log logn 0.989 0.987 0.967 0.969 0.954 0.952 0.950 0.962 0.962
log log n 0.992 0.992 0.968 0.972 0.957 0.955 0.950 0.964 0.965
logn 0.993 0.994 0.975 0.976 0.962 0.966 0.959 0.969 0.972√
n 0.994 0.995 0.975 0.976 0.967 0.972 0.968 0.973 0.975
n 0.994 0.995 0.975 0.976 0.969 0.972 0.968 0.975 0.976
β1,0,1
λn =
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
R
Ex. C
R√
log logn 0.952 0.962 0.952 0.954 0.950 0.953 0.947 0.952 0.954
log log n 0.956 0.964 0.954 0.955 0.950 0.957 0.948 0.956 0.957
logn 0.970 0.974 0.961 0.964 0.950 0.966 0.959 0.965 0.968√
n 0.971 0.975 0.963 0.968 0.954 0.973 0.965 0.974 0.978
n 0.971 0.975 0.987 0.987 0.979 0.980 0.975 0.983 0.984
Table 11: Monte Carlo estimates of coverage probabilities for the ACI method at the 95% nominal level
for different choices of λn. Here, β1,1,1 denotes the main effect of treatment and β1,0,1 denotes the intercept.
Estimates are constructed using 1000 datasets of size 150 drawn from each model, and 1000 bootstraps
drawn from each dataset. No coverage estimates are significantly below 0.95 at the 0.05 level. Models have
two treatments at each of two stages. Examples are designated NR = nonregular, NNR = near-nonregular,
R = regular.
β1,1,1
λn =
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
R
Ex. C
R√
log logn 0.490 0.490 0.481 0.481 0.483 0.471 0.474 0.484 0.484
log log n 0.502 0.502 0.488 0.488 0.487 0.475 0.477 0.491 0.491
logn 0.557 0.557 0.518 0.518 0.503 0.495 0.492 0.523 0.523√
n 0.583 0.582 0.533 0.533 0.513 0.514 0.511 0.540 0.540
n 0.586 0.586 0.538 0.538 0.525 0.521 0.519 0.543 0.543
β1,0,1
λn =
Ex. 1
NR
Ex. 2
NNR
Ex. 3
NR
Ex. 4
NNR
Ex. 5
NR
Ex. 6
R
Ex. A
R
Ex. B
R
Ex. C
R√
log logn 0.506 0.506 0.481 0.481 0.483 0.490 0.474 0.490 0.490
log log n 0.518 0.518 0.487 0.487 0.486 0.494 0.476 0.497 0.498
logn 0.574 0.574 0.517 0.517 0.502 0.517 0.493 0.540 0.541√
n 0.596 0.596 0.536 0.536 0.515 0.543 0.519 0.571 0.572
n 0.598 0.598 0.576 0.576 0.565 0.586 0.565 0.579 0.579
Table 12: Monte Carlo estimates of mean width of the ACI method at the 95% nominal level for different
choices of λn. Here, β1,1,1 denotes the main effect of treatment and β1,0,1 denotes the intercept. Estimates
are constructed using 1000 datasets of size 150 drawn from each model, and 1000 bootstraps drawn from each
dataset. No corresponding estimated coverages are significantly below 0.95 at the 0.05 level. Models have
two treatments at each of two stages. Examples are designated NR = nonregular, NNR = near-nonregular,
R = regular.
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E Appendix: The double bootstrap algorithm for selecting λ
Our algorithmic approach to choosing λn is similar to that used by Chakraborty et al. [2013] to choose m for
their m-out-of-n bootstrap method. To select λn, we first draw r bootstrapped datasets D(1), ...,D(r) from
the original dataset D. We take each of these in turn and compute an ACI bootstrap confidence interval
at level 1− α with parameter λn = τ
√
log log n for τ ∈ {0.125, 0.25, 0.5, 1, 2, 4}. (Because the ACI uses the
bootstrap itself, it actually uses double-bootstraps of D to compute each interval.) Using the parameters
estimated by Q-learning on the original D as ground truth, we compute for each value of τ the number of
bootstrapped datasets κ(τ) for which the ACI covers. We then select τ∗ to be the smallest τ that satisfies
κ(τ)/r > 1−α, and apply the ACI to the original dataset D using λ = τ∗√log log n. In our experiments we
used r = 100.
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